LUCY Innovative Eyewear Inc

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2024

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission file number 001-41392

 

INNOVATIVE EYEWEAR, INC.

(Exact name of registrant as specified in its charter)

 

Florida		85-0734861
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

 

11900 Biscayne Blvd., Suite 630, North Miami, Florida 33181

(Address of Principal Executive Offices, including zip code)

 

(954) 826-0329

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files.) Yes ☒   No ☐

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated Filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No ☒

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.00001 par value		LUCY		NASDAQ Capital Market
Warrants to purchase Common Stock		LUCYW		NASDAQ Capital Market

 

As of August 8, 2024, there were 1,570,569 shares of the Company’s common stock issued and outstanding.

 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

The discussions in this Quarterly Report on Form 10-Q contain forward-looking statements reflecting our current expectations that involve risks and uncertainties. These forward-looking statements include, but are not limited to, our strategy, competition, future operations and production capacity, our supply chain and logistics, future financial position, future revenues, projected costs, profitability, expected cost reductions, capital adequacy, expectations regarding demand and acceptance for our technologies, growth opportunities and trends in the market in which we operate, prospects and plans, and objectives of management. The words “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions, and expectations disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation, the risks set forth in Part II, Item 1A, “Risk Factors” in this Quarterly Report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We do not assume any obligation to update any forward-looking statements except as required by law.

 

 

Innovative Eyewear, Inc.

 

Table of Contents

 

				Page No.
Part I. Financial Information				1
Item 1.		Condensed Financial Statements (Unaudited)		1
		Condensed Balance Sheets as of June 30, 2024 (Unaudited) and December 31, 2023		1
		Condensed Statements of Operations for the three and six months ended June 30, 2024 and 2023 (Unaudited)		2
		Condensed Statements of Stockholders’ Equity for the three and six months ended June 30, 2024 and 2023 (Unaudited)		3
		Condensed Statements of Cash Flows for the six months ended June 30, 2024 and 2023 (Unaudited)		4
		Notes to the Financial Statements (Unaudited)		5
Item 2.		Management’s Discussion and Analysis of Financial Condition and Results of Operations		16
Item 3.		Quantitative and Qualitative Disclosures About Market Risk		31
Item 4.		Controls and Procedures		31
Part II. Other Information				32
Item 1.		Legal Proceedings		32
Item 1A.		Risk Factors		32
Item 2.		Unregistered Sales of Equity Securities and Use of Proceeds		32
Item 3.		Defaults Upon Senior Securities		32
Item 4.		Mine Safety Disclosures		32
Item 5.		Other Information		32
Item 6.		Exhibits		32
Signatures				33

 

 

Unless specifically set forth to the contrary, when used in this report the terms “Innovative Eyewear,” the “Company,” “we,” “our,” “us,” and similar terms refer to Innovative Eyewear, Inc. The information which appears on our website lucyd.co is not part of this report.

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

INNOVATIVE EYEWEAR, INC.

CONDENSED BALANCE SHEETS

June 30, 2024 (Unaudited) and December 31, 2023

 

		2024(1)				2023(1)
ASSETS
Current Assets
Cash and cash equivalents		$	5,896,889			$	4,287,447
Accounts receivable, net			61,613				93,211
Prepaid expenses			267,410				313,648
Inventory prepayment			70,779				323,520
Inventory			930,487				533,239
Due from Tekcapital and Affiliates			-				6,256
Other current assets			59,447				59,447
Total Current Assets			7,286,625				5,616,768
Non-Current Assets
Patent costs, net			349,195				286,429
Capitalized software costs			-				88,073
Property and equipment, net			130,645				154,848
Other non-current assets			92,715				72,644
TOTAL ASSETS		$	7,859,180			$	6,218,762
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued expenses		$	376,544			$	581,986
Deferred revenue			42,500				42,500
Due to Tekcapital and Affiliates			75,591				-
Total Current Liabilities			494,635				624,486
Non-Current Liabilities
Deferred revenue			20,450				35,450
TOTAL LIABILITIES			515,085				659,936
Commitments and contingencies (see Note 7)			-				-
Stockholders’ Equity
Common stock (par value $0.00001, 50,000,000 shares authorized, and 1,527,034 and 747,416 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively)(1)			15				7
Additional paid-in capital			28,233,205				22,528,234
Accumulated deficit			(20,889,125	)			(16,969,415	)
TOTAL STOCKHOLDERS’ EQUITY			7,344,095				5,558,826
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY		$	7,859,180			$	6,218,762

 

(1)

Retroactively adjusted the values of Common stock and Additional paid-in capital as well as the number of shares issued and outstanding in order to give effect to the Company’s 1-for-20 reverse stock split. See Note 2 and Note 11.

 

See accompanying Notes to the Condensed Financial Statements.

 

 

INNOVATIVE EYEWEAR, INC.

CONDENSED STATEMENTS OF OPERATIONS

For the three and six months ended June 30, 2024 and 2023

(Unaudited)

 

		Three Months Ended June 30,								Six Months Ended June 30,
		2024				2023				2024				2023
Revenues, net		$	308,682			$	169,929			$	692,153			$	314,850
Less: Cost of Goods Sold			(253,506	)			(199,745	)			(630,026	)			(334,375	)
Gross Profit (Deficit)			55,176				(29,816	)			62,127				(19,525	)
Operating Expenses:
General and administrative			(1,295,299	)			(968,354	)			(2,404,245	)			(1,962,126	)
Sales and marketing			(442,433	)			(103,643	)			(1,103,728	)			(362,940	)
Research and development			(256,802	)			(197,478	)			(473,103	)			(348,647	)
Related party management fee			(35,000	)			(35,000	)			(70,000	)			(70,000	)
Total Operating Expenses			(2,029,534	)			(1,304,475	)			(4,051,076	)			(2,743,713	)
Other Income			25,959				47,586				69,239				47,662
Interest Expense			-				(1,097	)			-				(3,036	)
Total Other Income (Expense), net			25,959				46,489				69,239				44,626
Net Loss		$	(1,948,399	)		$	(1,287,802	)		$	(3,919,710	)		$	(2,718,612	)
Weighted average number of shares outstanding(1)			1,044,211				503,670				896,685				476,357
Loss per share, basic and diluted(1)		$	(1.87	)		$	(2.56	)		$	(4.37	)		$	(5.71	)

 

(1)

Retroactively adjusted shares outstanding and per share information to give effect to the Company’s 1-for-20 reverse stock split. See Note 2 and Note 11.

 

See accompanying Notes to the Condensed Financial Statements.

 

 

INNOVATIVE EYEWEAR, INC.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

For the three and six months ended June 30, 2024 and 2023

(Unaudited)

 

		Common Stock								Additional Paid In				Accumulated				Total Stockholders’
		Shares(1)				Amount				Capital				Deficit				Equity
Balances as of January 1, 2024			747,416			$	7			$	22,528,234			$	(16,969,415	)		$	5,558,826
Issuance of shares to third party service provider			15,000				-				81,900				-				81,900
Issuance of shares related to vesting of restricted share units			815				-				-				-				-
Stock-based compensation			-				-				232,154				-				232,154
Net loss			-				-				-				(1,971,311	)			(1,971,311	)
Balances as of March 31, 2024			763,231			$	7			$	22,842,288			$	(18,940,726	)		$	3,901,569
At-the-Market Offerings			284,471				3				2,324,576								2,324,579
First Registered Direct Offering			210,043				2				737,298								737,300
Second Registered Direct Offering			263,159				3				2,134,048								2,134,051
Issuance of shares to brand ambassador			4,500				-				21,690								21,690
Issuance of shares related to vesting of restricted share units			1,630				-				-				-				-
Stock-based compensation			-				-				173,305				-				173,305
Net loss			-				-				-				(1,948,399	)			(1,948,399	)
Balances as of June 30, 2024			1,527,034			$	15			$	28,233,205			$	(20,889,125	)		$	7,344,095
Balances as of January 1, 2023			434,042			$	4			$	14,330,412			$	(10,305,987	)		$	4,024,429
Exercises of warrants by stockholders			22,926				-				1,532,250				-				1,532,250
Stock-based compensation			-				-				424,431				-				424,431
Net loss			-				-				-				(1,430,810	)			(1,430,810	)
Balances as of March 31, 2023			456,968			$	4			$	16,287,093			$	(11,736,797	)		$	4,550,300
Exercises of stock options			11,518				-				17,650				-				17,650
Exercises of warrants by stockholders			18,019				-				1,204,200				-				1,204,200
Exercises of warrants related to private placement transaction			8,417				-				391,268				-				391,268
Second public offering			252,494				3				4,115,685				-				4,115,688
Stock-based compensation			-				-				(40,180	)			-				(40,180	)
Net loss			-				-				-				(1,287,802	)			(1,287,802	)
Balances as of June 30, 2023			747,416			$	7			$	21,975,716			$	(13,024,599	)		$	8,951,124

 

(1)

Retroactively adjusted the values of Common stock and Additional paid-in capital as well as the number of shares issued and outstanding in order to give effect to the Company’s 1-for-20 reverse stock split. See Note 2 and Note 11.

 

See accompanying Notes to the Condensed Financial Statements.

 

 

INNOVATIVE EYEWEAR, INC.

CONDENSED STATEMENTS OF CASH FLOWS

For the six months ended June 30, 2024 and 2023

(Unaudited)

 

		2024				2023
Operating Activities
Net Loss		$	(3,919,710	)		$	(2,718,612	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation			59,951				17,816
Amortization			15,297				28,979
Non-cash interest expense			-				3,036
Stock-based compensation expense			405,459				384,251
Expenses paid by Tekcapital and Affiliates			157,835				151,467
(Recovery of) provision for doubtful accounts			(3,687	)			5,814
Write-off of previously-capitalized software costs			88,073				-
Changes in operating assets and liabilities:
Accounts receivable			50,285				(26,211	)
Accounts payable and accrued expenses			(205,442	)			(129,714	)
Prepaid expenses			96,160				(60,603	)
Inventory			(144,507	)			(734,042	)
Other assets			-				(10,000	)
Contract assets and liabilities			3,597				1,560
Net cash flows from operating activities			(3,396,689	)			(3,086,259	)
Investing Activities
Loan made to Tekcapital Europe, Ltd.			(767,940	)			-
Repayment of amounts loaned to Tekcapital Europe, Ltd.			767,940				-
Purchases of debt securities (U.S. Treasury bills)			-				(1,949,204	)
Patent costs			(78,063	)			(131,622	)
Purchases of property and equipment			(35,748	)			(34,435	)
Net cash flows from investing activities			(113,811	)			(2,115,261	)
Financing Activities
Proceeds from second public offering			-				4,115,688
Proceeds from at-the-market offerings			2,324,579				-
Proceeds from first registered direct offering			737,300				-
Proceeds from second registered direct offering			2,134,051				-
Proceeds from exercises of warrants			-				3,127,718
Proceeds from exercise of stock options			-				17,650
Repayment of related party convertible debt			-				(109,499	)
Repayment of amounts due to Tekcapital and Affiliates			(75,988	)			(184,701	)
Net cash flows from financing activities			5,119,942				6,966,856
Net Change In Cash			1,609,442				1,765,336
Cash at Beginning of Period		$	4,287,447			$	3,591,109
Cash at End of Period		$	5,896,889			$	5,356,445
Significant Non-Cash Transactions
Expenses paid for by Tekcapital and Affiliates, reported as increase in Due to/from Tekcapital and Affiliates and related party convertible debt			157,835				151,467
Issuance of shares for prepayment to third party service provider			81,900				-
Issuance of shares for prepayment to brand ambassador			21,690				-

 

See accompanying Notes to the Condensed Financial Statements.

 

 

INNOVATIVE EYEWEAR, INC.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

June 30, 2024 and 2023 (Unaudited)

 

NOTE 1 – GENERAL INFORMATION

 

Innovative Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd., a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively, together with Lucyd Ltd., “Tekcapital and Affiliates”), which owned approximately 19% of our issued and outstanding shares of common stock and was our largest shareholder as of June 30, 2024. Innovative Eyewear has licensed the exclusive rights to the Lucyd^® brand from Lucyd Ltd., which includes the exclusive use of all of Lucyd’s intellectual property, including our main product, Lucyd Lyte^® glasses.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

The accompanying condensed balance sheet as of December 31, 2023 (which has been derived from audited financial statements) and the unaudited interim condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.

 

In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the periods presented have been included. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for future periods or the full year.

 

Certain prior period amounts have been reclassified to conform to current period presentation; approximately $22,000 of capitalized costs related to the Company’s website previously reported within Capitalized software costs are now reported within Property and equipment, net.

 

Change in Capital Structure

As described more fully in Note 11, effective July 18, 2024, the Company effected a 1-for-20 reverse stock split for all of its issued and outstanding common stock. All share and per share amounts presented in these financial statements and accompanying notes, including but not limited to shares issued and outstanding, dollar amounts of common stock and additional paid-in capital, earnings/(loss) per share, and warrants and options, have been retroactively adjusted for all periods presented in order to reflect this change in capital structure. There were no changes to the total number of authorized common shares or par value per common share as a result of this change.

 

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant uncertainties associated with the current geopolitical and economic environment.

 

5

 

 

Cash Equivalents

All highly liquid investments with original maturities of three months or less, including money market funds, certificates of deposit, and U.S. Treasury bills purchased three months or less from maturity, are considered cash equivalents.

 

Receivables and Credit Policy

Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. For direct-to-consumer sales, payment is required before product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net 30” payment terms on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on “net 30” payment terms, the customer is provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for much we will bill the customer via credit card.

 

Accounts receivable are reported net of an allowance for doubtful accounts. The allowance for doubtful accounts is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management’s assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Receivable balances are written-off against the allowance when such balances are deemed to be uncollectible.

 

A roll forward of the allowance for doubtful accounts for the six months ended June 30, 2024 and 2023 is as follows:

 

Schedule of allowance for doubtful accounts
		2024				2023
Balance at January 1		$	25,772			$	92,646
Bad debt expense (recovery)			(3,687	)			5,814
Write-offs			-				(142	)
Other			217				-
Balance at June 30		$	22,302			$	98,318

 

Inventory

The Company’s inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product.

 

Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. Such provisions were $0 and $31,637 as of June 30, 2024 and December 31, 2023, respectively.

 

As of June 30, 2024 and December 31, 2023, the Company recorded an inventory prepayment in the amount of $70,779 and $323,520, respectively, related to down payments for eyewear purchased from the manufacturer, prior to shipment of the product that occurred after the respective balance sheet dates.

 

6

 

 

Intangible Assets

Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents. The Company reviews its intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.

 

Capitalized Software

The Company has incurred software development costs related to development of the Vyrb application, and had previously capitalized approximately $88,000 of these costs related to coding, development, and testing subsequent to establishing technical feasibility of the app, as it was the Company’s intention to market and sell this software externally.

 

Although we launched Vyrb as an open beta version in 2021, and continued to add new features to the app throughout 2022 and 2023, we had not officially launched the Vyrb app. During 2024, management decided to shift our primary software development focus to the Lucyd app, which was launched in April 2023 as a free application that enables the user to converse with the extremely popular ChatGPT AI language model on our glasses. Certain elements and features developed for the Vyrb app may potentially be incorporated into future releases of the Lucyd app.

 

Based on this decision, during the three and six months ended June 30, 2024, we expensed the previously-capitalized Vyrb software development costs totalling approximately $88,000 to research and development expense.

 

Property and Equipment

Property and equipment assets are depreciated using the straight-line method over their estimated useful lives or lease terms if shorter. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed as incurred.

 

Income Taxes

The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

 

The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.

 

The Company periodically assesses the realizability of its net deferred tax assets. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.

 

Stock-Based Compensation

The Company recognizes compensation expense for stock-based awards to employees and directors and others based on the grant date fair value of such awards. Forfeitures are accounted for as a reduction of compensation expense in the period when such forfeitures occur.

 

7

 

 

For stock option awards, the Black-Scholes-Merton option pricing model is used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility.

 

●

The expected term of the stock options is estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).

 

●

The share price volatility is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies.

 

●

The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.

 

For awards of restricted stock units and shares of common stock, the fair value of the award is based on the quoted market price of our common shares on the NASDAQ stock exchange.

 

Revenue Recognition

Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.com.

 

To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.

 

In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received. During the six months ended June 30, 2024 and 2023, we recognized $15,000 of revenue for each period, that was included in the contract liability balances as of January 1, 2024 and 2023, respectively.

 

All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.

 

For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. U.S. consumers enjoy free USPS first class postage on orders over $149, with faster delivery options available for extra cost, for sales processed through our website. For Amazon sales, shipping is free for U.S. consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.

 

8

 

 

For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store, and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.

 

For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order. If collectibility of substantially all of the contract consideration is probable, revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor, and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to retail store partners and distributors includes volume discounts, due to the nature of large quantity orders. The pricing does not include shipping. Due to the nature of wholesale retail orders, no marketplace fees are applicable, only credit card processing fees.

 

We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason and receive a full refund for frames (prescription lenses excluded) within the first 7 days for sales made through our website (Lucyd.co), 30 days for sales made through Amazon, and 30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns). As of January 2024, our return policy was updated to prohibit discretionary returns of prescription lenses. Additionally in January 2024, we instituted a standard $15 restocking fee for standard frame returns, which is deducted from applicable refunds to cover shipping and restocking costs.

 

For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $8,536 and $40,933 as June 30, 2024 and December 31, 2023, respectively.

 

Amounts billed to a customer for shipping and handling are reported as revenues. Costs incurred for shipping and handling are included in cost of goods sold at the time the related revenue is recognized.

 

NOTE 3 – GOING CONCERN

 

The Company has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditions in the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverse conditions may include recession, downturn, or otherwise, changes in regulations or restrictions in imports, competition, or changes in consumer taste. These adverse conditions could affect the Company’s financial condition and the results of its operations.

 

The Company meets its day-to-day working capital requirements using monies raised through sales of eyewear and issuances of equity. During the three months ended June 30, 2024, the Company raised approximately $5.2 million of net proceeds through the issuance of equity via a combination of at-the-market offerings and registered direct offerings (see Note 9 for details). The Company has also entered into an agreement with a related party, under which the Company may borrow up to $1.25 million (see Note 6 for details); as of June 30, 2024, the Company has not borrowed any amounts under this agreement. The Company’s forecasts and projections indicate that the Company expects to have sufficient liquidity to fund operations through at least the next 12 months. However, the Company may raise additional funds this year if management believes it would be beneficial.

 

9

 

 

NOTE 4 – INCOME TAX PROVISION

 

At the end of each interim reporting period, the Company estimates its effective tax rate expected to be applied for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods. The Company has not recorded a tax provision for the three and six months ended June 30, 2024 and 2023 as it maintains a full valuation allowance against its net deferred tax assets.

 

NOTE 5 – TANGIBLE AND INTANGIBLE ASSETS

 

Schedule of property, plant and equipment
		June 30,				December 31,
Property & Equipment		2024				2023
Mobile Kiosk Display		$	160,381			$	127,333
Computer Equipment			44,901				44,901
Office Equipment			12,991				10,291
Internal-Use Software and Website Costs			53,300				53,300
Property and equipment, gross			271,573				235,825
Less: Accumulated depreciation			(140,928	)			(80,977	)
Property and equipment, net		$	130,645			$	154,848

 

Depreciation expense for the three months ended June 30, 2024 and 2023 was $38,292 and $18,672, respectively.

 

Depreciation expense for the six months ended June 30, 2024 and 2023 was $59,951 and $28,979, respectively.

 

Schedule of intangible assets
		June 30,				December 31,
Finite-lived intangible assets		2024				2023
Patent Costs		$	407,295			$	329,232
Intangible assets, gross			407,295				329,232
Less: Accumulated amortization			(58,100	)			(42,803	)
Intangible assets, net		$	349,195			$	286,429

 

Amortization expense for the three months ended June 30, 2024 and 2023 was $7,483 and $11,860, respectively.

 

Amortization expense for the six months ended June 30, 2024 and 2023 was $15,297 and $17,816, respectively.

 

NOTE 6 – RELATED PARTY TRANSACTIONS AND AGREEMENTS

 

Convertible Note and Due to Tekcapital and Affiliates

Through December 31, 2023, the Company had the availability of, but not the contractual right to, intercompany financing from Tekcapital and Affiliates in the form of either cash advances or borrowings under a convertible note (as discussed below).

 

The convertible notes balances were $61,356 at January 1, 2023. In January 2023, the Company borrowed an additional $48,143 under such convertible notes, and subsequently repaid the outstanding balances of the convertible notes in full in February 2023. No further amounts were borrowed under these convertible notes, and the convertible notes matured on December 1, 2023 with no amounts outstanding.

 

10

 

 

New Lucyd Ltd. Financing Agreement

On March 1, 2024, the Company entered into an agreement with Lucyd Ltd. pursuant to which the Company can receive up to $1,250,000 either (a) in services provided by Lucyd Ltd. to the Company or (b) in cash upon request of funds by the Company. Once funds or services are received by the Company, it will issue a convertible note to Lucyd Ltd. that will bear interest at 10% per annum and include the option to convert the note into shares of the Company’s common stock upon certain conversion events. Upon issuance, the convertible note will have a maturity date of September 1, 2025, at which time all outstanding principal and accrued interest, if any, will be payable in full in cash or in the Company’s common stock. The Company will be able to prepay the convertible notes at any time with the written consent of Lucyd Ltd. The Company has not borrowed any amounts under this agreement.

 

Loan to Tekcapital Europe, Ltd.

On January 11, 2024, the Company entered into an intercompany loan agreement (as lender) with Tekcapital Europe, Ltd. (as borrower) and Tekcapital Plc, the parent of Tekcapital Europe, Ltd. Pursuant to this agreement, the Company loaned 600,000 British pounds sterling (equivalent to approximately $768,000) to Tekcapital Europe, Ltd. The loan bore simple interest at a rate of 10% per annum and was required to be repaid on or before April 11, 2024. Tekcapital Plc executed the agreement as guarantor for Tekcapital Europe, Ltd. on the full amount of the loan.

 

Tekcapital Europe, Ltd. repaid substantially all of the principal balance of the loan in March 2024. As of March 31, 2024, the only amounts remaining outstanding and payable to us under the loan were 7,616 British pounds sterling of principal and 10,717 British pounds sterling of accrued interest (in total, approximately $23,000). These remaining amounts were repaid to us during the three months ended June 30, 2024, and as of June 30, 2024, no amount remains outstanding or payable under this agreement.

 

Management Service Agreement

The Company has entered into a management services agreement with Tekcapital Europe, Ltd., for which the Company is billed at $35,000 quarterly. While the agreement does not stipulate a specific maturity date, it can be terminated with 30 calendar days written notice by any party.

 

The related party currently provides the following services:

 

●

Support and advice to the Company in accordance with their area of expertise;

 

●

Research, technical and legal review, recruitment, software development, marketing, public relations, and advertisement; and

 

●

Advice, assistance, and consultation services to support the Company or in relation to any other related matter.

 

During the three months ended June 30, 2024 and 2023, the Company incurred $35,000 in each respective period under the management services agreement. During the six months ended June 30, 2024 and 2023, the Company incurred $70,000 in each respective period under the management services agreement.

 

Rent of Office Space

Under an agreement between the Company and Tekcapital, Tekcapital bills the Company for an allocation of rent paid by Tekcapital on the Company’s behalf. The Company recognized $23,274 and $22,992 of expense related to this month-to-month arrangement for the three months ended June 30, 2024 and 2023, respectively, and recognized $46,505 and $45,760 of expense related to this month-to-month arrangement for the six months ended June 30, 2024 and 2023, respectively.

 

11

 

 

NOTE 7 – COMMITMENTS AND CONTINGENCIES

 

Legal Matters

We are not currently the subject of any material pending legal proceedings; however, we may from time to time become a party to various legal proceedings arising in the ordinary course of business.

 

On January 3, 2024, we settled and resolved certain matters with a third party, including a complaint that had been brought before the International Trade Commission and an investigation instituted by the International Trade Commission in 2023, and entered into a multi-year non-exclusive license agreement with the third party covering multiple smart eyewear patents (as described more fully below).

 

License Agreements

In 2022 and 2023, we entered into various multi-year license agreements which grant us the right to sell certain branded smart eyewear, including the Nautica, Eddie Bauer, and Reebok brands worldwide. These agreements require us to pay royalties based on a percentage of net retail and wholesale sales during the period of the license, and also require guaranteed minimum royalty payments.

 

The aggregate future minimum payments due under these license agreements are as follows:

 

Schedule of future minimum payments due
Remainder of 2024			$	-
2025				436,000
2026				834,000
2027				1,290,000
2028				1,543,000
Thereafter (through 2033)				9,907,000
Total			$	14,010,000

 

Also, on January 3, 2024, entered into a multi-year non-exclusive license agreement with a third party (IngenioSpec, LLC) for multiple smart eyewear patents. Pursuant to this license agreement, the Company added licenses for 46 new patents to its portfolio of owned and licensed patents and applications. The Company fully prepaid this license for the term of the agreement, and as of June 30, 2024 does not have any obligation for future payments under this agreement.

 

Leases

Our executive offices are located at 11900 Biscayne Blvd., Suite 630 Miami, Florida 33181. Our executive offices are provided to us by a related party (see Note 6). We consider our current office space adequate for our current operations.

 

Other Commitments

See related party management services agreement discussed in Note 6.

 

12

 

 

NOTE 8 – STOCK-BASED COMPENSATION

 

Stock Options

Summary information regarding the number of options, exercise price, and remaining contractual life as of and during the six months ended June 30, 2024 (as retroactively adjusted for the reverse stock split described in Note 11) is as follows:

 

Schedule of number of share options and the weighted average exercise price outstanding
		Weighted Average Exercise Price per share ($)				Options (Number)				Weighted Average Remaining Contractual Life (Years)
As at January 1, 2024			41.60				144,726				2.22
Granted			8.40				500
Exercised			-				-
Forfeited / Expired			21.84				(30,750	)
As at June 30, 2024			46.77				114,476				2.14
Exercisable as at June 30, 2024			57.44				83,540				1.46

 

As of June 30, 2024, the aggregate intrinsic value for all options outstanding as well as all options exercisable was zero 0, and unrecognized stock option expense of approximately $293,000 remains to be recognized over the next 0.71 years.

 

During the six months ended June 30, 2024, we granted options to purchase an aggregate of 500 shares of common stock at $8.402 per share to an employee, of which 1/5 vested immediately, and 1/5 were to vest on each six-month anniversary of the grant date. The options were to expire on January 11, 2029. However, the employee later separated from the Company, and these options were all forfeited or expired.

 

Restricted Stock Units

During the three and six months ended June 30, 2024, we recognized $5,075 and $10,150 of expense, respectively, related to restricted stock units awarded in 2023; as of June 30, 2024, unrecognized restricted stock unit expense of approximately $8,500 remains to be recognized between July 1, 2024 and November 30, 2024.

 

Stock Grants

On March 28, 2024, we entered into an agreement for a third party to provide us with financial advisory and investment banking services, for a minimum term of six months. As consideration for the services provided to the Company, we issued to the counterparty 15,000 shares of our common stock. The total value of consideration transferred, measured using the fair value of our common stock at the date of issuance, was $81,900. During the three and six months ended June 30, 2024, we recognized $40,950 of expense related to this arrangement, and will recognize the remaining expense of $40,950 during the three months ending September 30, 2024.

 

On April 1, 2024, we entered into a brand ambassador agreement with an individual for a two-year term. As compensation for the first year of the agreement, we issued the individual 4,500 shares of our common stock. The value of the consideration transferred, measured using the fair value of our common stock at the date of issuance, was $21,690. During the three and six months ended June 30, 2024, we recognized $5,423 of expense related to this arrangement, and will recognize the remaining expense for these shares awarded of $16,267 on a straight-line basis from July 1, 2024 through March 31, 2025.

 

13

 

 

NOTE 9 – STOCKHOLDERS’ EQUITY

 

At-the-Market Offerings

On April 15, 2024, the Company entered into an at-the-market offering agreement with H.C. Wainwright & Co., LLC, as sales agent (“HCW”), relating to the sale of common stock.

 

From April 15, 2024 through April 28, 2024, the Company sold 2,828 shares of common stock and received approximately $13,000 of gross proceeds before deducting sales agent commissions and offering expenses. The net proceeds received by the Company from these transactions amounted to approximately $12,000.

 

Following the first registered direct offering described below, from May 2, 2024 through May 24, 2024, the Company sold 34,900 shares of common stock and received approximately $536,000 of gross proceeds before deducting sales agent commissions and offering expenses. The net proceeds received by the Company from these transactions amounted to approximately $518,000.

 

Following the second registered direct offering described below, from June 13, 2024 through June 30, 2024, the Company sold 246,743 shares of common stock and received approximately $1,918,000 of gross proceeds before deducting sales agent commissions and offering expenses, and the net proceeds received by the Company from these transactions amounted to approximately $1,845,000.

 

The Company also paid $50,000 of legal fees to HCW during the three months ended June 30, 2024; this payment has been reflected in the unaudited condensed financial statements as a reduction to additional paid in capital, as it represents a related cost of the at-the-market equity offering transactions.

 

First Registered Direct Offering

On May 1, 2024, the Company closed on a registered direct offering of 210,043 shares of its common stock and, in a concurrent private placement, warrants to purchase up to 210,043 shares of common stock at an exercise price of $4.88 per share, for a combined purchase price per share and warrant of $4.88. In exchange, the Company received approximately $1.0 million of gross proceeds, before deducting underwriting discounts and offering expenses. In addition, the Company issued to the placement agent warrants to purchase up to 15,754 shares of common stock at an exercise price of $6.10 per share. The net proceeds received by the Company from this transaction amounted to approximately $837,000. We intend to use the net proceeds of this offering primarily for working capital and general corporate purposes.

 

Approximately $100,000 of the net proceeds received from this registered direct offering were used to pay a former agent for their waiver of a contractual right of first refusal; such payment has been reflected in the unaudited condensed financial statements as a reduction to additional paid in capital, as it represents a related cost of the equity transaction.

 

Second Registered Direct Offering

On May 29, 2024, the Company closed on a registered direct offering of 263,159 shares of its common stock and, in a concurrent private placement, warrants to purchase up to 263,159 shares of common stock at an exercise price of $9.50 per share, for a combined purchase price per share and warrant of $9.50. In exchange, the Company received approximately $2.5 million of gross proceeds, before deducting underwriting discounts and offering expenses. In addition, the Company issued to the placement agent warrants to purchase up to 19,737 shares of common stock at an exercise price of $11.876 per share. The net proceeds received by the Company from this transaction amounted to approximately $2.1 million. We intend to use the net proceeds of this offering primarily for working capital and general corporate purposes.

 

Other Matters

During the three and six months ended June 30, 2024, the Company made a release payment of $325,000 to a shareholder counterparty for the waiver of certain of that counterparty’s pre-existing contractual rights related to the Company’s equity offerings described above. This payment is reflected within General and administrative expenses in the condensed statements of operations.

 

14

 

 

NOTE 10 – EARNINGS PER SHARE

 

The Company calculates earnings/(loss) per share data by calculating the quotient of earnings/(loss) divided by the weighted average number of common shares outstanding during the respective period.

 

Due to the net losses for all periods presented in the condensed statements of operations, all shares underlying the common stock options, common stock warrants, and related party convertible debt were excluded from the earnings per share calculation due to their anti-dilutive effect.

 

The calculation of net earnings/(loss) per share (as retroactively adjusted for the reverse stock split described in Note 11) is as follows:

 

Schedule of calculation of net earnings per common share - basic and diluted
		For the three months ended								For the six months ended
		June 30, 2024				June 30, 2023				June 30, 2024				June 30, 2023
Basic and diluted:
Net loss		$	(1,948,399	)		$	(1,287,802	)		$	(3,919,710	)		$	(2,718,612	)
Weighted-average number of common shares			1,044,211				503,670				896,685				476,357
Basic and diluted net loss per common share		$	(1.87	)		$	(2.56	)		$	(4.37	)		$	(5.71	)

 

NOTE 11 – SUBSEQUENT EVENTS

 

Reverse Stock Split

At our annual meeting of shareholders on July 8, 2024, the Company’s shareholders approved an amendment to the Company’s articles of incorporation to effect a reverse stock split of our issued and outstanding common stock at a ratio between 1-for-14 and 1-for-24. Subsequently, the board of directors authorized a reverse stock split in a ratio of 1-for-20 shares, and we filed with the Florida Secretary of State a certificate of amendment to our articles of incorporation.

 

Effective July 18, 2024, each 20 shares of the Company’s issued and outstanding common stock were combined into one share of common stock, except to the extent that the reverse stock split would have resulted in any of the Company’s stockholders owning a fractional share, in which case such fractional share was rounded up to the next highest whole share. Additionally, pursuant to their terms, the shares of common stock underlying the Company’s outstanding stock options and warrants were similarly adjusted along with corresponding adjustments to their exercise prices.

 

All share and per share amounts presented in these financial statements and accompanying notes, included but not limited to shares issued and outstanding, earnings/(loss) per share, and warrants and options, as well as the dollar amounts of common stock and additional paid-in capital, have been retroactively adjusted for all periods presented in order to reflect this change in capital structure.

 

There was no change to the total number of authorized common shares of 50,000,000, and there was no change in the par value per common share of $0.00001.

 

At-the-Market Offerings

On July 11, 2024, the Company further amended its prospectus document, and offered to sell up to $1,446,737 of shares of its common stock from time to time, through HCW acting as agent.

 

From July 12, 2024 through August 8, 2024, the Company sold 43,535 shares of common stock and received approximately $252,000 of gross proceeds before deducting sales agent commissions and offering expenses. The net proceeds received by the Company from these transactions amounted to approximately $242,000.

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion and analysis of our financial condition and results of operations should be read together with our financial statements and the related notes and the other financial information included elsewhere in this Quarterly Report. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those discussed below and elsewhere in this Quarterly Report.

 

Overview

 

Our mission is to Upgrade Your Eyewear^®. We develop and sell cutting-edge smart eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering vision correction and protection. Our smart eyewear is a fusion of headphones with glasses, bringing vision correction and protection together with digital connectivity and clear audio, while also offering a safer solution for listening to music outdoors (as compared to in-ear headphones). The convenience of having a Bluetooth headset and comfortable glasses in one, especially for those who are already accustomed to all-day eyewear use, offers a lifestyle upgrade at a price most consumers can afford.

 

Our flagship product, Lucyd Lyte^®, enables the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform many common smartphone tasks hands-free. Notably, by the end of 2024 the Company anticipates completing its mission to introduce a smart upgrade for all four of the major types of eyewear: prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses. We believe this will expand our customer base significantly by having a large eyeglass and sunglass offering that better aligns with the needs of optical retailers. To date, most Lucyd products have been designed for sunglass use, so adding styles designed specifically for indoor eyeglass use has the opportunity to attract a much larger customer base and more optical retail partners. Additionally, the Lucyd Armor and Reebok^® Powered by Lucyd frames will align with the style and performance needs of safety and sport eyewear users respectively, for which we have not previously had a suitable product offering.

 

Products and History

 

In January 2020, we introduced our first beta product and began market testing.

 

In January 2021, we officially launched our first commercial product, Lucyd Lyte. This initial product offering embodied our goal of creating smart eyewear for all-day wear that looks like and is priced similarly to designer eyewear, but is also lightweight and comfortable, and enables the wearer to remain connected to their digital lives. The product was initially launched with six styles, and in September 2021, an additional six styles were added, including the Company’s first titanium-front smart eyewear. A final four styles were added to this collection in 2022, including the Company’s first matte finish and tortoise style models, along with improvements to hinge design.

 

In the first quarter of 2022 we introduced a virtual try-on kiosk for select retail stores. This device introduces our products to prospective retail customers and enables them to digitally try-on our line of smart glasses in a touch-free manner. In the fourth quarter of 2022, we completed development of core audio eyewear product improvements, such as upgrading all frames to quadraphonic sound, which was subsequently rolled out across all of our new eyewear models.

 

In February 2023, we launched version 2.0 of our Lucyd Lyte eyewear with 15 different styles, incorporating several key breakthroughs for the smart eyewear product category – including a four-speaker audio array, 12-hour music playback and call time, and improved styling as well as technical upgrades. In October 2023, we launched six new styles of smart eyewear, branded as Lyte XL, bringing even more advancements – including patent-pending flexible hinges for a more comfortable fit and a wider range of suitable head sizes, significant improvements to speaker and microphone quality, thinner and more ergonomic temples, and post-consumer recycled packaging.

 

 

Also during 2023, we completed upgrades to our accessory products, including the charging dock and virtual try-on kiosk. The patent-pending Lucyd charging dock was upgraded to version 2.0 edition, featuring auto-adjusting connectors to fit any size of smart eyewear we produce, a new charging status LED, and USB data capability, enabling it to be used as a USB hub for computers in addition to a charging hub. The Lucyd virtual try-on kiosk was replaced with a fully modular display system, with eight available components for stores to mix and match to suit their display needs. The display can be deployed as a countertop display or freestanding, making it suitable for almost any retail environment.

 

In January 2024, we launched the Nautica^® Powered by Lucyd smart eyewear collection in eight different styles, along with various branded accessories including a power brick, cleaning cloth, and a slipcase adorned with the iconic Nautica sail logo. This collection introduced the Company’s first “global fit” style, which supports low nose bridge customers.

 

In April 2024, we launched the Eddie Bauer^® Powered by Lucyd smart eyewear collection in four different styles, which showcases the first-to-market rimless smart eyewear design. We believe the Eddie Bauer collection is the Company’s most premium product to date, and features brushed titanium hardware, improved sound quality, and includes the patent-pending Lucyd Dock with every unit.

 

We anticipate launching the Reebok^® Powered by Lucyd smart eyewear collection later in the second half of 2024, followed by a Reebok^® Optical Smart Eyewear collection in the first half of 2025.

 

Our current product offering consists of 33 different models, which offers a similar amount of style variety as many traditional eyewear collections. The Company is continuously iterating and improving its frame lineup, offering a mixture of “Lucyd icons” (styles that have consistently performed well since the introduction of Lucyd Lyte) and new styles seasonally to align with market trends and evolving consumer demand. All styles are available with 80+ different lens types, resulting in thousands of variations of products currently available. The Company currently has over 100 licensed patents and applications.

 

Since the launch of Lucyd Lyte, we have witnessed interest and demand from customers throughout the United States and have sold thousands of our smart glasses. Within six months of the launch of Lucyd Lyte, several optical stores in the United States and Canada have onboarded the product and we have had discussions with several other large eyewear chains regarding our frames. We believe smart eyewear is a product category whose time has come, and we believe we are well positioned to capitalize on and help develop this exciting new sector – where eyewear meets electronics in a user-friendly, mass market format, priced similarly to designer eyewear.

 

Software and Apps

 

In April 2023, we introduced a major software upgrade for our glasses with the launch of the Lucyd app for iOS and Android. This free application enables the user to converse with the extremely popular ChatGPT AI language model on our glasses, to instantly gain the benefit of one of the world’s most powerful AI assistants in a hands-free ergonomic interface. The app deploys a powerful and unique Siri integration with the Open AI API for ChatGPT, developed internally by the Company. The Company has filed a patent application related to this software.

 

In the second quarter of 2024, we added a Pro version of the app, which provides unlimited ChatGPT interactions and priority tech support for a modest monthly or annual fee. The Company anticipates that this will become a new revenue stream for our business, and will represent our first diversification in product revenue from frames and lenses.

 

In July 2024, we launched a new feature called “Walkie” for the Lucyd app, which enables thousands of users to join each other on walkie-talkie style communication channels. This feature was designed with the upcoming smart safety glass product in mind, to enable coworking teams to communicate freely on smart eyewear. We plan to launch more new features for the Lucyd app in the future, such as an audio equalizer enabling the user to optimize sound output for different types of content such as calls and podcasts, a “Find My Glasses” feature, and touch control customizations.

 

 

We believe these developments make our Lucyd eyewear perhaps the smartest smartglasses available today, and represent a significant marketing opportunity for our core smartglass products.

 

A large part of our strategy is not just to provide a leading smart eyewear platform, but to build a highly functional mobile software and interactive retail fixture ecosystem to support user adoption and “stickiness” with our products. While the Lucyd app provides additional value to end users after purchase, we also wanted to make the purchase process itself more engaging and tech-forward. To this end, we have also developed all-new interactive LCD retail fixtures, featuring a new proprietary kiosk app that we have just recently developed in-house. These new displays offer a complete Lucyd experience, including virtual try-on, social media content, detailed product info and videos, and seamless music demos. The new display systems, installed with the Lucyd shopping app, are expected to provide an immersive onboarding experience for prospective customers in retail stores carrying our frames, and will start shipping to partners in the fourth quarter of 2024.

 

Key Factors Affecting Performance

 

Expansion of retail points of purchase

 

In addition to sustained growth of our e-commerce business, we believe our future revenues are correlated positively with our placement of Lucyd glasses in optical stores, as well as sporting goods stores and other specialty stores. To support this growth, we have partnered with Windsor Eyes as our premier distributor for the optical market. Windsor Eyes brings decades of experience in the eyewear industry and a team of experienced, professional eyewear sales reps. In July 2024, they have just started to market our frames, and have already introduced our frames into three new eyewear retailers. We currently offer an expansive line of 33 different styles and several accessories (including our co-branded product offerings with Nautica and Eddie Bauer), and are in the process of expanding our product offerings to include co-branded eyewear with other well-known brands like Reebok. In total, the Company expects to offer 38 total smart eyewear models by the end of 2024.

 

Retail store client retention and re-orders

 

Our ability to sustain and increase revenue is correlated positively with our ability to receive re-orders from stores, either directly or through our wholesale distributors. To support our sales to retail stores directly, we offer a strong co-op marketing program that includes free and paid store display materials. Additionally, we consistently incorporate retail partner feedback directly into our frames to better serve our end users.

 

As part of this strategy, we have launched a new modular display system with engaging video screens and audio testing capabilities for our resellers to help educate their in-store customers about Lucyd Lyte and enable customers to try them on. This proprietary display system is central to our efforts to introduce traditional retail customers to Lucyd eyewear, and we are planning further enhancements to our merchandising displays to enable more immersive experiences. As of June 30, 2024, 73 digital display systems have been deployed to retailers. Enhanced countertop and freestanding displays with large, interactive screens and engaging social media content are planned to launch in the fourth quarter of 2024.

 

Investing in business growth

 

We believe that people care about what they wear on their faces, and because we understand that customers have diverse preferences about the shape, size, and design of their eyewear, we aim to continuously invest in the design and development of new models in an effort to provide the consumer with a wide selection of styles, colors, and finishes.

 

We are offering a strong co-op marketing program with retail stores, and intend to expand our sales, marketing, and brand ambassador teams to broaden our brand awareness and online presence.

 

 

Key Performance Indicators

 

Store Count (B2B)

 

We believe that one of the key indicators for our business is the number of retail stores onboarded to sell Lucyd Lyte. We started onboarding our first retail stores in June 2021. Currently, we have over 350 retail stores selling Lucyd Lyte primarily in the United States and Canada. Based on the existing demand for our products, current distribution, and recently consummated supply agreements, we anticipate that our products will be available in a significant number of new third-party retail locations in 2024.

 

Customer Ratings (B2C)

 

The Lucyd Lyte version 2.0 product is receiving higher ratings online compared to our previous products, indicating that customers are appreciative of improvements in product design, functionality, and build quality. Many of our Lyte XL variants carry a 4.0/5 rating or higher. This is a strong signal of positive feedback on our products that indicates our ability to grow and scale with America’s largest online retailer and other platforms.

 

Number of online orders (B2C)

 

For our e-commerce business, we track the number of online orders as an indicator of the success of our online marketing efforts. As of June 30, 2024, we had over 20,000 cumulative total orders from customers online since inception. We believe that the addition of new styles, as well as further investment in brand awareness, product ambassadors, and influencer campaigns, will enable continued growth of online orders in the foreseeable future. We expect to allocate a significant portion of our advertising expenditures towards influencer marketing programs.

 

Components of Results of Operations

 

Revenues

 

Our revenue is generated from the sales of prescription and non-prescription optical glasses and sunglasses, and shipping charges associated with these purchases, which are charged to the customer. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.com.

 

Our flagship Lucyd Lyte XL brand frames are priced at $179 on acetate models and $199 on titanium models for non-prescription glasses across all of our online channels. Our co-branded Nautica^® Powered by Lucyd and Eddie Bauer^® Powered by Lucyd frames are priced at $199 – $219 and $249 – $299, respectively.

 

When adding a prescription lens upgrade to our glasses on the Lucyd.co website, the price can increase from between $40 for a basic clear prescription lens, all the way up to $449 for our proprietary Blueshift transitional blue light lenses in a progressive high index (ultra-thin) format. Glasses with prescription lenses are provided by the Company through our website Lucyd.co, while our sales through Amazon and to our retail partners only include non-prescription glasses (with rare exceptions, such as a reseller ordering a customized unit for display purposes). Lens customizations remain an important product differentiator and upselling opportunity.

 

U.S. Lucyd.co consumers enjoy free USPS first class postage on orders over $149, with faster delivery options available for extra cost, for sales processed through our website. For Amazon sales, shipping is free for U.S. consumers while international customers pay shipping charges. Any costs associated with fees charged by the online platforms (Shopify for our Lucyd.co website and Amazon.com) are not recharged to customers. We charge applicable state sales taxes for online channels and all other marketplaces on which sell.

 

Our wholesale pricing for eyewear sold to retail store partners and distributors includes volume discounts, due to the nature of large quantity orders. The pricing does not include shipping. Due to the nature of wholesale retail orders, no marketplace fees are applicable, only credit card processing fees.

 

 

Cost of Goods Sold

 

Cost of goods sold includes the costs incurred to acquire materials, assemble, and sell our finished products.

 

For retail sales placed through one of our e-commerce channels, these costs include (i) product costs stated at the lesser of cost and net realizable value and inclusive of inventory reserves, (ii) freight, import, and inspection costs, (iii) optical laboratory costs for prescription glasses, (iv) merchant fees, (v) fees paid to third-party e-commerce platforms, and (vi) cost of shipping the product to the consumer.

 

For wholesale sales, these costs include (i) product costs stated at the lesser of cost and net realizable value and inclusive of inventory reserves, (ii) freight, import, and inspection costs, and (iii) credit card fees.

 

When consumers place their orders directly on our website, we save approximately 12% - 15% on marketplace fees compared with orders placed through third-party platforms like Amazon and eBay.

 

We expect our cost of goods sold to fluctuate as a percentage of net revenue primarily due to product mix, customer preferences and resulting demand, customer shipping costs, and management of our inventory and merchandise mix.

 

Over time, we expect our total cost of goods sold on a per unit basis to decrease as a result of an increase in scale. Increase in scale is achieved as a result of increase in volumes from both business to consumer and business to business (retail store) orders. We continue to expand our products with line extensions and new models and broaden our presence in retail stores carrying our products.

 

Gross Profit and Gross Margin

 

We define gross profit as net revenue less cost of goods sold. Gross margin is gross profit expressed as a percentage of net revenue.

 

Our gross margin may fluctuate in the future based on a number of factors, including the cost at which we can obtain, transport, and assemble our inventory, the rate at our vendor network expands, and how effective we can be at controlling costs in any given period. Over time, we anticipate that our cost of goods sold, on a per unit basis, will decrease with scale, and this will likely have a positive impact on our gross margins.

 

Operating Expenses

 

Our operating expenses consist primarily of:

 

	●	general and administrative expenses that primarily include payroll and consulting expenses, IT & software, legal, and other administrative expenses;
	●	sales and marketing expenses including cost of online advertising, marketing agency fees, influencers, trade shows, and other initiatives;
	●	related party management fees for a range of back-office services provided by Tekcapital; and
	●	research and development expenses related to (i) development of new styles and features of our smart eyewear, (ii) development and improvement of our e-commerce website, and (iii) development of software and apps for wearables.

 

Interest and Other Income, Net

 

Interest and other income, net, primarily includes interest, dividends, and investment returns from our investments in money market funds and U.S. Treasury bills, as well as interest income and expense related to loans with related parties.

 

 

Results of Operations – Quarterly

 

The following table summarizes our results of operations for the three months ended June 30, 2024 (the “current quarter”) and the three months ended June 30, 2023 (the “prior year quarter”):

 

		Three months ended								Three months ended
		June 30,								June 30,
		2024								2023								Change
Revenues, net		$	308,682				100	%		$	169,929				100	%		$	138,753				82	%
Less: Cost of Goods Sold			(253,506	)			82	%			(199,745	)			118	%			(53,761	)			27	%
Gross Profit (Deficit)			55,176				18	%			(29,816	)			-18	%			84,992				-285	%
Operating Expenses:
General and administrative			(1,295,299	)			420	%			(968,354	)			570	%			(326,945	)			34	%
Sales and marketing			(442,433	)			143	%			(103,643	)			61	%			(338,790	)			327	%
Research and development			(256,802	)			83	%			(197,478	)			116	%			(59,324	)			30	%
Related party management fee			(35,000	)			11	%			(35,000	)			21	%			-				0	%
Total Operating Expenses			(2,029,534	)			657	%			(1,304,475	)			768	%			(725,059	)			56	%
Other Income (Expense)			25,959				-8	%			47,586				-28	%			(21,627	)			-45	%
Interest Expense			-				0	%			(1,097	)			1	%			1,097				-100	%
Total Other Income (Expense), net			25,959				-8	%			46,489				-27	%			(20,530	)			-44	%
Net Loss		$	(1,948,399	)			631	%		$	(1,287,802	)			758	%		$	(660,597	)			51	%

 

Revenues

 

Our revenues for the three months ended June 30, 2024 were $308,682, representing an increase of 82% as compared to revenues of $169,929 during the three months ended June 30, 2023. The increase in revenue was primarily driven by significant growth in the e-commerce channel, with net sales through our Lucyd.co website growing by more than 200% from the prior year quarter, and was primarily attributable to our recent new product launches (including the Lyte XL collection in the fourth quarter of 2023, and the co-branded Nautica^® Powered by Lucyd and Eddie Bauer^® Powered by Lucyd collections in the first half of 2024). We believe our brand partnerships play a significant role in our revenue growth by offering a more diversified product line that speaks to consumers from different demographics (for example, Nautica^® generally appeals to a more fashion-forward customer than Lucyd Lyte, and Eddie Bauer^® generally appeals to an older demographic than our other lines).

 

Wholesale revenue decreased approximately 8% from the prior year quarter, largely driven by a change in our focus from small, independent retailers to major national retailers, the latter of which have slower product approval and purchasing cycles. However, we believe that focusing on introducing our product in major national retailers will have a significant positive impact on the Company’s revenues in the next 3 to 21 months.

 

For the three months ended June 30, 2024, approximately 59% of sales were processed on our online store (Lucyd.co), 25% on Amazon.com, and 16% with reseller partners. This sales channel mix positively impacted our revenue for the current quarter as compared with the prior year quarter, due to the fact we charge an additional $35 to $275 for our prescription lenses available only on Lucyd.co. For the three months ended June 30, 2024, we generated an aggregate of $227,545 of revenue from sales of non-prescription frames and accessories, and $81,137 from sale of frames with prescription lenses. All of the $76,641 in sales generated on Amazon.com during the current quarter were for non-prescription frames and accessories, as we only offer prescription lenses through our website. Of the $182,521 in online sales generated through Lucyd.co, $81,137 was related to frames with prescription lenses and $101,384 was related to glasses with non-prescription lenses. E-commerce sales remain to be the most material portion of our sales to date; however, out of all of our sales channels, we believe that the wholesale optical channel represents the most promising opportunity for growth. We anticipate that as smart eyewear becomes more normalized for prescription wear, major national eye care providers will begin to onboard smart eyewear products, and we believe we are the value leader in that sector.

 

 

For the three months ended June 30, 2023, approximately 32% of sales were processed on our online store (Lucyd.co), 36% on Amazon, and 32% with reseller partners. For the three months ended June 30, 2023, we generated $139,144 of revenue from sales of non-prescription frames and accessories, and $30,784 from sales of frames with prescription lenses. All of the $62,212 in sales generated on Amazon.com during the 2023 period were for non-prescription frames and accessories as we only offer prescription lenses through our website. Of the $52,389 in online sales generated through Lucyd.co, $30,784 was related to frames with prescription lenses and $21,605 was related to glasses with non-prescription lenses.

 

Cost of Goods Sold

 

Our total cost of goods sold increased to $253,506 for the three months ended June 30, 2024, as compared to $199,745 for the prior year quarter. This year-over-year increase of 27% was primarily driven by higher sales volumes during the current quarter as compared with the prior year quarter, partially offset by the impacts of certain period costs and other one-off items, most notably including approximately $44,000 of custom duties and taxes expensed in the prior year quarter which did not recur in the current quarter.

 

Cost of frames increased by approximately 124% from the prior year quarter, which was primarily attributable to the combination of (i) higher cost of goods sold associated with the new Eddie Bauer^® Powered by Lucyd collection, due to the increased number of components, deluxe finishes, and materials, and (ii) the timing of physical inventory verification and cycle counts, and associated inventory adjustments.

 

Cost of lenses increased by approximately 65% from the prior year quarter, which was primarily attributable to sales volume increases, partially offset by management’s efforts to reduce lens fulfilment costs. We also recently contracted with a new lower-cost lens supplier in July 2024, which is expected to further reduce lens costs by as much as 40% starting in the third quarter of 2024.

 

Cost of goods sold for the three months ended June 30, 2024 included the cost of frames of $160,023; cost of prescription lenses incurred with our third-party vendor of $54,714; commissions, affiliate referral fees, and e-commerce platform fees of $27,205; shipping and logistics costs of $24,754; and inventory adjustment credits of $(13,990). Out of our total cost of goods sold for the current quarter of $253,506, $54,714 related to orders with prescription lenses, while $198,792 pertained to non-prescription orders. We anticipate that our cost of goods sold will improve in future periods as new products (i.e., Lucyd Armor and Reebok^® Powered by Lucyd) from a new supplier are launched in the fourth quarter of 2024, as the frames for these product lines are designed for shorter wear periods, and accordingly have fewer components, thus reducing their price. We estimate that the unit cost of these new product lines will be at least 30% lower than our Lucyd Lyte models.

 

Cost of goods sold for the three months ended June 30, 2023 included the cost of frames of $71,564; cost of prescription lenses incurred with our third-party vendor of $33,092; commissions, affiliate referral fees, and e-commerce platform fees of $50,794; and custom duties and importation fees of $44,295. Out of our total cost of goods sold for the three months ended June 30, 2023 of $199,745, $33,092 related to orders with prescription lenses, while $166,653 pertained to non-prescription orders.

 

We anticipate further growth in sales in 2024, along with corresponding growth in total cost of goods sold, primarily from additional product related costs. As we continue to refine our product mix with sales data, we anticipate reducing our unit costs by focusing only on the highest volume, market-tested styles. We have also launched new Lucyd Shift and Lucyd Blueshift transitional lenses in place of branded third-party transitional lenses, offering similar functionality for a lower cost of goods, while also enabling a slightly lower cost to the customer. Additionally, we have recently engaged a new local lens supplier based in Miami, Florida, starting in July 2024, which should significantly reduce our cost of lens fulfilment costs across the board starting in the third quarter of 2024, by as much as 40% per prescription order.

 

Gross Profit (Deficit)

 

Our gross profit for the current quarter was $55,176, as compared to a gross deficit of $(29,816) for the prior year quarter. Our gross margin was positive 18% in the current quarter and negative 18% in the prior year quarter, representing an improvement of approximately 36 percentage points from the prior year period.

 

 

This increase in gross profit and gross margin was primarily attributable to certain period costs and other one-off items, including approximately $44,000 of custom duties and taxes expensed in the prior year quarter which did not recur in the current quarter, and inventory adjustment credits of approximately $14,000 in the current quarter. Together, these items represented approximately 22 percentage points of the total improvement in gross margin. The remaining improvement in gross margin was primarily attributable to the combination of (i) greater economies of scale as a result of higher unit volumes, and (ii) management’s recent efforts to reduce lens fulfilment costs (i.e. the change in our return policy in January 2024 to prohibit custom lens refunds, and the switch to a more affordable lab).

 

Overall, our gross profit indicates a positive trend, as our increase in net sales of 82% compared with our increase in cost of goods sold of 27% reflects our sales growth outpacing our fixed unit costs. This is reflective of reduced discounting online as we seek to improve our suitability as a provider to brick and mortar channels.

 

Ultimately, we believe that the majority of our business will come from frame sales to distributors and eyewear retailers, who will outfit lenses themselves for the final customer. We anticipate that the launch of Reebok co-branded products later this year will help us progress towards our long-term goal of shifting our sale mix over time more towards the wholesale channel, which carries higher margins for us as such sales to our third-party retail store partners do not include the cost of prescription lenses.

 

Operating Expenses

 

Our operating expenses increased by 56% to $2,029,534 for the three months ended June 30, 2024, as compared to $1,304,475 for the three months ended June 30, 2023. This increase was primarily due to the continued investments in the future growth and development of our business and included, but was not limited to, the following:

 

General and administrative expenses

 

Our general and administrative expenses increased by $326,945 or 34% to $1,295,299 for the three months ended June 30, 2024, as compared to $968,354 for the prior year quarter. This increase was primarily attributable to a $325,000 release payment made to a shareholder counterparty for the waiver of certain of that counterparty’s pre-existing contractual rights related to the Company’s equity offerings during the current quarter.

 

The Company maintains a lean staff salaried at market rates, and a significant portion of our general and administrative expenses consist of corporate overhead type costs which are fixed or semi-fixed in nature (e.g., rent, compliance, legal and professional services, etc.); as such, our general and administrative expenses are not expected to scale up significantly as our revenue increases.

 

Sales and marketing expenses

 

Our sales and marketing expenses increased by approximately $339,000 or 327% to $442,433 for the three months ended June 30, 2024, as compared to $103,643 for the three months ended June 30, 2023. This year-over-year increase is primarily attributable to the fact that the prior year quarter included a reversal of approximately $309,000 of previously-recognized stock-based compensation for certain individuals within the Company’s sales and marketing function whose awards expired without ever having vested, as the related performance conditions (sales quotas) for those awards were not met. Going forward, we expect our sales and marketing expense to typically fall within the range of $350,000 to $500,000 per quarter, with some variation to align with the timing of major product launches in order to maximize impact of spending.

 

From a long-term perspective, while we expect that sales and marketing expenses will scale up to some degree as our revenue increases, we anticipate that such increases in sales and marketing expenses will be mitigated somewhat by our planned focus on growing the wholesale optical channel, which, due to the nature of that channel, inherently does not require costly marketing campaigns to acquire each customer and as a result typically carries a lower marketing cost per unit sold. Additionally, we generally expect that a retailer who is successful with our products will reorder in large quantities, also without significant marketing expenditure.

 

 

Research and development costs

 

Our research and development costs increased by 30% to $256,802 for the three months ended June 30, 2024, as compared to $197,478 for the three months ended June 30, 2023. This increase was primarily attributable to the write-off of approximately $88,000 of previously-capitalized software costs related to the development of the Vyrb app (which was launched as an open beta version in 2021, and has had new features added over time, but had never been officially launched) as a result of management’s decision in 2024 to de-emphasize the Vyrb app in favor of shifting our primary software development focus to the Lucyd app. Certain elements and features developed for the Vyrb app may potentially be incorporated into future releases of the Lucyd app.

 

Related party management fee

 

Our related party management fee was $35,000 for each of the three-month periods ended June 30, 2024 and 2023, based on the terms of the management services agreement between us and Tekcapital.

 

Other Income (Expense), net

 

Total other income (expense), net in the three months ended June 30, 2024 was $25,959. This amount was primarily comprised of dividends from our investments in money market funds.

 

Total other income (expense), net in the three months ended June 30, 2023 was $46,489, and was primarily comprised of refunds of certain amounts that had been previously charged to the Company from the Parent and Affiliates in prior periods.

 

 

Results of Operations – Year to Date

 

The following table summarizes our results of operations for the six months ended June 30, 2024 (the “current six months”) and the six months ended June 30, 2023 (the “prior year six months”):

 

		Six months ended June 30, 2024								Six months ended June 30, 2023								Change
Revenues, net		$	692,153				100	%		$	314,850				100	%		$	377,303				120	%
Less: Cost of Goods Sold			(630,026	)			91	%			(334,375	)			106	%			(295,651	)			88	%
Gross Profit (Deficit)			62,127				9	%			(19,525	)			-6	%			81,652				-418	%
Operating Expenses:
General and administrative			(2,404,245	)			347	%			(1,962,126	)			623	%			(442,119	)			23	%
Sales and marketing			(1,103,728	)			159	%			(362,940	)			115	%			(740,788	)			204	%
Research and development			(473,103	)			68	%			(348,647	)			111	%			(124,456	)			36	%
Related party management fee			(70,000	)			10	%			(70,000	)			22	%			-				0	%
Total Operating Expenses			(4,051,076	)			585	%			(2,743,713	)			871	%			(1,307,362	)			48	%
Other Income (Expense)			69,239				-10	%			47,662				-15	%			21,577				45	%
Interest Expense			-				0	%			(3,036	)			1	%			3,036				-100	%
Total Other Income (Expense), net			69,239				-10	%			44,626				-14	%			24,613				55	%
Net Loss		$	(3,919,710	)			566	%		$	(2,718,612	)			863	%		$	(1,201,098	)			44	%

 

Revenues

 

Our revenues for the six months ended June 30, 2024 were $692,153, representing an increase of 120% as compared to revenues of $314,850 during the six months ended June 30, 2023. The increase in revenue was primarily attributable to significant growth in the e-commerce channel, largely driven by our significant investments in advertising and marketing initiatives during the latter portion of 2023 and through the current period, combined with recent new product launches (including the Lyte XL collection in the fourth quarter of 2023 and the co-branded Nautica^® Powered by Lucyd and Eddie Bauer^® Powered by Lucyd collections in the current six months).

 

Net sales through our Lucyd.co website and Amazon.com grew by more than 300% and by approximately 77%, respectively, from the prior year six months. This growth in e-commerce sales was partially offset by significant price discounts granted in the current six months (particularly during the first quarter of 2024), in order to respond to aggressive discounts offered by key competing products and support our continued market share growth.

 

Wholesale revenue decreased approximately 39% from the prior year six months, largely driven by a change in our focus from small, independent retailers to major national retailers, the latter of which have slower product approval and purchasing cycles. However, we believe that focusing on introducing our product in major national retailers will have a significant positive impact on the Company’s revenues in the next 3 to 21 months.

 

 

For the six months ended June 30, 2024, approximately 63% of sales were processed on our online store (Lucyd.co), 28% on Amazon.com, and 9% with reseller partners. This sales channel mix positively impacted our revenue for the current six months as compared with the prior year six months, due to the fact we charge an additional $35 to $275 for our prescription lenses available only on Lucyd.co. For the six months ended June 30, 2024, we generated an aggregate of $500,287 of revenue from sales of non-prescription frames and accessories, and $191,866 from sale of frames with prescription lenses. All of the $190,260 in sales generated on Amazon.com during the current six months were for non-prescription frames and accessories, as we only offer prescription lenses through our website. Of the $438,441 in online sales generated through Lucyd.co, $191,866 was related to frames with prescription lenses and $246,575 was related to glasses with non-prescription lenses. E-commerce sales remain to be the most material portion of our sales to date; however, out of all of our sales channels, we believe that the wholesale optical channel represents the most promising opportunity for growth. We anticipate that as smart eyewear becomes more normalized for prescription wear, major national eye care providers will begin to onboard smart eyewear products, and we believe we are the value leader in that sector.

 

For the six months ended June 30, 2023, approximately 33% of sales were processed on our online store (Lucyd.co), 34% on Amazon, and 33% with reseller partners. For the six months ended June 30, 2023, we generated $265,689 of revenue from sales of non-prescription frames and accessories, and $47,702 from sales of frames with prescription lenses. All of the $107,257 in sales generated on Amazon.com during the period were for non-prescription frames and accessories as we only offer prescription lenses through our website. Of the $102,657 in online sales generated through Lucyd.co, $47,702 was related to frames with prescription lenses and $54,955 was related to glasses with non-prescription lenses.

 

Cost of Goods Sold

 

Our total cost of goods sold increased to $630,026 for the six months ended June 30, 2024, as compared to $334,375 for the prior year six months. This year-over-year increase of 88% was primarily driven by higher sales volumes during the current six months as compared with the prior year comparable period, partially offset by the impacts of certain period costs and other one-off items, most notably including approximately $44,000 of custom duties and taxes expensed in the prior year six months which did not recur in the current six months.

 

Cost of frames increased by approximately 137% from the prior year six months, primarily related to the increase in sales volumes and also partially attributable to the combination of (i) higher cost of goods sold associated with the new Eddie Bauer^® Powered by Lucyd collection, due to the increased number of components, deluxe finishes, and materials, and (ii) the timing of physical inventory verification and cycle counts, and associated inventory adjustments.

 

Cost of lenses increased by approximately 186% from the prior year six months, mainly driven by (i) the introduction of our new proprietary Blueshift premium lenses in August 2023, which are more expensive than other lenses to produce, and (ii) sales channel mix, as a higher relative proportion of our sales in the current six months were through our online store (Lucyd.co), and the cost of prescription lenses attributable to this channel increased our cost of goods sold while not impacting cost of goods sold for sales realized through Amazon or retail store partners. These cost increases were partially offset by management’s efforts to reduce lens fulfilment costs.

 

Cost of goods sold for the six months ended June 30, 2024 notably included, but was not limited to, the cost of frames of $345,001; cost of prescription lenses incurred with our third-party vendor of $157,782; commissions, affiliate referral fees, and e-commerce platform fees of $70,031; shipping and logistics costs of $40,668; and product certification costs of $29,100. Out of our total cost of goods sold for the current six months of $630,026, $157,782 related to orders with prescription lenses, while $472,244 pertained to non-prescription orders. We anticipate that our cost of goods sold will improve in future periods as new products (i.e., Lucyd Armor and Reebok^® Powered by Lucyd) from a new supplier are launched in the fourth quarter of 2024, as the frames for these product lines are designed for shorter wear periods, and accordingly have fewer components, thus reducing their price. We estimate that the unit cost of these new product lines will be at least 30% lower than our Lucyd Lyte models.

 

 

Cost of goods sold for the six months ended June 30, 2023 notably included, but was not limited to, the cost of frames of $136,303; cost of prescription lenses incurred with our third-party vendor of $55,215; commissions, affiliate referral fees, and e-commerce platform fees of $67,382; custom duties and importation fees of $44,295; and quality assurance costs related to our products sold of $11,700. Out of $334,375 of our total cost of goods sold for the six months ended June 30, 2023, $55,215 related to orders with prescription lenses, while $279,159 pertained to non-prescription orders.

 

We anticipate further growth in sales in 2024, along with corresponding growth in total cost of goods sold, primarily from additional product related costs. As we continue to refine our product mix with sales data, we anticipate reducing our unit costs by focusing only on the highest volume, market-tested styles. We have also launched new Lucyd Shift and Lucyd Blueshift transitional lenses in place of branded third-party transitional lenses, offering similar functionality for a lower cost of goods, while also enabling a slightly lower cost to the customer. Additionally, we have recently engaged a new local lens supplier based in Miami, Florida, starting in July 2024, which should significantly reduce our cost of lens fulfilment costs across the board starting the third quarter of 2024, by as much as 40% per prescription order.

 

Gross Profit (Deficit)

 

Our gross profit for the current six months was $62,127, as compared to a gross deficit of $(19,525) for the prior year six months. Our gross margin was positive 9% in the current six months and negative 6% in the prior year six months, representing an improvement of approximately 15 percentage points from the prior year period.

 

This change in gross profit and gross margin was primarily attributable to certain period costs and other one-off items, including approximately $44,000 of custom duties and taxes expensed in the prior year six months which did not recur in the current year, inventory adjustment credits of approximately $14,000 in the current six months, and product certification costs of approximately $29,000 in the current six months. Together, these items represented approximately 12 percentage points of the total improvement in gross margin. The remaining improvement in gross margin was primarily attributable to greater economies of scale as a result of higher unit volumes.

 

We are continuing to work with all of suppliers and vendors, including our prescription lens suppliers and our key frame suppliers, to reduce our unit costs. Ultimately, we believe that the majority of our business will come from frame sales to distributors and eyewear retailers, who will outfit lenses themselves for the final customer. We anticipate that the launches of more co-branded products later this year will help us progress towards our long-term goal of shifting our sale mix over time more towards the wholesale channel, which carries higher margins for us as such sales to our third-party retail store partners do not include the cost of prescription lenses.

 

Operating Expenses

 

Our operating expenses increased by 48% to $4,051,076 for the six months ended June 30, 2024, as compared to $2,743,713 for the six months ended June 30, 2023. This increase was primarily due to the continued investments in the future growth and development of our business and included, but was not limited to, the following:

 

General and administrative expenses

 

Our general and administrative expenses increased by 23% to $2,404,245 for the six months ended June 30, 2024, as compared to $1,962,126 for the prior year six months. This increase was largely driven by the combination of (i) a $325,000 release payment made to a shareholder counterparty during the current six months for the waiver of certain of that counterparty’s pre-existing contractual rights related to the Company’s equity offerings during the second quarter of 2024, (ii) the cost of various licensing agreements we have entered into in order to support our co-branding initiatives and expand our patent portfolio, which are assessed annually in January, and (iii) higher investor relations costs. These increases were partially offset by a decrease in salary and employee-related expenses recorded to general and administrative expenses, primarily due to certain employees spending a higher relative proportion of their time working on research and development activities.

 

The Company maintains a lean staff salaried at market rates, and a significant portion of our general and administrative expenses consist of corporate overhead type costs which are fixed or semi-fixed in nature (e.g., rent, compliance, legal and professional services, etc.); as such, our general and administrative expenses are not expected to scale up significantly as our revenue increases.

 

 

Sales and marketing expenses

 

Our sales and marketing expenses increased by 204% to $1,103,728 for the six months ended June 30, 2024, as compared to $362,940 for the six months ended June 30, 2023. This year-over-year increase is primarily attributable to the combination of the following main drivers:

 

●

the restructuring of our e-commerce business during the prior year six months, during which we temporarily paused and postponed our marketing spending, and management made a tactical decision to preserve a significant portion of our marketing budget for later in the year, in order to better align the timing of marketing spending with major new product launches and thus maximize impact. In the latter portion of 2023 and continuing through the current six months, we have significantly increased our advertising and marketing efforts, particularly in the areas of spending on paid ads on websites and social media platforms, in order to drive growth in our revenues and market share.

 

●

the fact that the prior year six months included a reversal of approximately $309,000 of previously-recognized stock-based compensation for certain individuals within the Company’s sales and marketing function whose awards expired without ever having vested, as the related performance conditions (sales quotas) for those awards were not met.

 

From a long-term perspective, while we expect that sales and marketing expenses will scale up to some degree as our revenue increases, we anticipate that such increases in sales and marketing expenses will be mitigated somewhat by our planned focus on growing the wholesale optical channel, which, due to the nature of that channel, inherently does not require costly marketing campaigns to acquire each customer and as a result typically carries a lower marketing cost per unit sold. Additionally, we generally expect that a retailer who is successful with our products will reorder in large quantities, also without significant marketing expenditure

 

Research and development costs

 

Our research and development costs increased by 36% to $473,103 for the six months ended June 30, 2024, as compared to $348,647 for the six months ended June 30, 2023.

 

This increase was primarily attributable to the write-off of approximately $88,000 of previously-capitalized software costs related to the development of the Vyrb app (which was launched as an open beta version in 2021, and has had new features added over time, but had never been officially launched) as a result of management’s decision in 2024 to de-emphasize the Vyrb app in favor of shifting our primary software development focus to the Lucyd app. Certain elements and features developed for the Vyrb app may potentially be incorporated into future releases of the Lucyd app.

 

Also contributing to the year-over-year increase were (i) an increase in allocated salary and employee-related expenses, primarily due to certain employees spending a higher relative proportion of their time working on research and development activities, and (ii) new mold costs associated with the creation of the safety and sport (Reebok) product format.

 

Related party management fee

 

Our related party management fee was $70,000 for each of the six months ended June 30, 2024 and 2023, based on the terms of the management services agreement between us and Tekcapital.

 

Other Income (Expense), net

 

Total other income (expense), net in the six months ended June 30, 2024 was $69,239. This amount was primarily comprised of dividends from our investments in money market funds, and, to a lesser extent, interest income earned on a short-term loan to a related party.

 

Total other income (expense), net in the six months ended June 30, 2023 was $44,626, and was primarily comprised of refunds of certain amounts that had been previously charged to the Company from the Parent and Affiliates in prior periods.

 

 

Liquidity and Capital Resources

 

As of June 30, 2024 and December 31, 2023, our cash and cash equivalents were approximately $5.9 million and $4.3 million, respectively. Our working capital (current assets less current liabilities) was approximately $6.8 million and $5.0 million as of June 30, 2024 and December 31, 2023, respectively.

 

Cash Flow

 

		Six months ended June 30, 2024				Six months ended June 30, 2023
Net cash flows from operating activities		$	(3,396,689	)		$	(3,086,259	)
Net cash flows from investing activities			(113,811	)			(2,115,261	)
Net cash flows from financing activities			5,119,942				6,966,856
Net Change in Cash		$	1,609,442			$	1,765,336

 

Net cash flows used in operating activities for the six months ended June 30, 2024 are primarily reflective of our net loss for the period, resulting from our operating costs to support and grow our business, including employee-related costs, sales and marketing, and research and development.

 

Net cash flows used in investing activities for the six months ended June 30, 2024 are mainly related to the continuing growth and expansion of our patent portfolio.

 

Net cash flows used in financing activities for the six months ended June 30, 2024 are mainly driven by proceeds from equity offerings as described below.

 

Equity Offerings

 

At-the-Market Offerings

 

On April 15, 2024, we entered into an at-the-market offering agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC, as sales agent (“HCW”), relating to the sale of common stock. Under this agreement, during the three months ended June 30, 2024, we sold a total of 284,471 shares and received approximately $2.5 million of gross proceeds, before deducting sales agent commissions and offering expenses. The net proceeds received by the Company from sales under the ATM Agreement amounted to approximately $2.4 million. We intend to use the net proceeds from sales under the ATM Agreement primarily for working capital and general corporate purposes.

 

First Registered Direct Offering

 

On May 1, 2024, the Company closed on a registered direct offering of 210,043 shares of its common stock and, in a concurrent private placement, warrants to purchase up to 210,043 shares of common stock at an exercise price of $4.88 per share, for a combined purchase price per share and warrant of $4.88. In exchange, the Company received approximately $1.0 million of gross proceeds, before deducting underwriting discounts and offering expenses. In addition, the Company issued to the placement agent warrants to purchase up to 15,754 shares of common stock at an exercise price of $6.10 per share. The net proceeds received by the Company from this transaction amounted to approximately $0.8 million. We intend to use the net proceeds of this offering primarily for working capital and general corporate purposes.

 

Approximately $0.1 million of the net proceeds received from this registered direct offering were used to pay a former agent for their waiver of a contractual right of first refusal; such payment has been reflected in the unaudited condensed financial statements as a reduction to additional paid in capital, as it represents a related cost of this equity transaction.

 

 

Second Registered Direct Offering

 

On May 29, 2024, the Company closed on a registered direct offering of 263,159 shares of its common stock and, in a concurrent private placement, warrants to purchase up to 263,159 shares of common stock at an exercise price of $9.50 per share, for a combined purchase price per share and warrant of $9.50. In exchange, the Company received approximately $2.5 million of gross proceeds, before deducting underwriting discounts and offering expenses. In addition, the Company issued to the placement agent warrants to purchase up to 19,737 shares of common stock at an exercise price of $11.876 per share. The net proceeds received by the Company from this transaction amounted to approximately $2.1 million. We intend to use the net proceeds of this offering primarily for working capital and general corporate purposes.

 

Other Factors

 

We expect that operating losses could continue in the foreseeable future as we continue to invest in the expansion and development of our business. We believe our existing cash and cash equivalents (including the proceeds from the equity offerings described above), plus the availability to borrow funds via the March 2024 related party agreement with Lucyd Ltd., will be sufficient to fund our operations for at least the next twelve months.

 

However, our future capital requirements will depend on many factors, including, but not limited to, growth in the number of retail store customers, licenses, the needs of our e-commerce business and retail distribution network, expansion of our product and software offerings, and the timing of investments in technology and personnel to support the overall growth of our business. To the extent that current and anticipated future sources of liquidity are insufficient to fund our future business activities and requirements, we may be required to seek additional equity or debt financing. The sale of additional equity would result in additional dilution to our stockholders. The incurrence of debt financing would result in debt service obligations and the instruments governing such debt could provide for operating and financing covenants that would restrict our operations. There can be no assurances that we will be able to raise additional capital. In the event that additional financing is required from outside sources, we may not be able to negotiate terms acceptable to us or at all. Geopolitical and macroeconomic factors could cause disruption in the global financial markets, which could reduce our ability to access capital and negatively affect our liquidity in the future. If we are unable to raise additional capital when required, or if we cannot expand our operations or otherwise capitalize on our business opportunities because we lack sufficient capital, our business, results of operations, financial condition, and cash flows would be adversely affected.

 

Off-Balance Sheet Arrangements

 

As of June 30, 2024, we did not have any off-balance sheet arrangements.

 

Critical Accounting Policies and Significant Estimates

 

There have been no material changes in our critical accounting policies and significant estimates from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on March 25, 2024.

 

Subsequent Events – Change in Capital Structure

 

On July 8, 2024, the Company filed with the Florida Secretary of State a Certificate of Amendment to the Company’s Certificate of Incorporation (the “Certificate of Amendment”) which became effective on July 16, 2024 to effect a one-for-twenty (1-for-20) reverse stock split (the “Reverse Stock Split”) of shares of the Company’s common stock, par value $0.00001 per share (the “Common Stock”). The Reverse Stock Split was approved by the Company’s stockholders at the 2024 annual meeting on July 8, 2024.

 

 

As a result of the Reverse Stock Split, each twenty (20) shares of issued and outstanding Common Stock were automatically combined into one (1) issued and outstanding share of Common Stock, without any change in the par value per share. No fractional shares were issued as a result of the Reverse Stock Split; to the extent that the Reverse Stock Split would have resulted in any of the Company’s stockholders owning a fractional share, such fractional share was rounded up to the next highest whole share. On July 18, 2024, immediately following the Reverse Stock Split, the number of shares of Common Stock outstanding was reduced from 28,029,462 shares to 1,534,858 shares. Additionally, pursuant to their terms, the shares of Common Stock underlying the Company’s outstanding stock options and warrants were similarly adjusted along with corresponding adjustments to their exercise prices. The number of authorized shares of Common Stock under the Certificate of Incorporation remained unchanged.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

We carried out an evaluation, under the supervision and with the participation of our management including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13(a)-15(b) of the Exchange Act. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as a result of material weaknesses in our internal control over financial reporting, our disclosure controls and procedures were not effective as of June 30, 2024.

 

There was no change in our internal control over financial reporting during the second quarter of fiscal year 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

Part II. Other Information

 

Item 1. Legal Proceedings

 

We are not currently the subject of any material pending legal proceedings; however, we may from time to time become a party to various legal proceedings arising in the ordinary course of business.

 

Item 1A. Risk Factors

 

There have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on March 25, 2024.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not Applicable.

 

Item 5. Other Information.

 

None.

 

Item 6. Exhibits

 

31.1		Certification of Principal Executive Officer of Innovative Eyewear, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2		Certification of Principal Financial Officer of Innovative Eyewear, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1		Certification of Principal Executive Officer of Innovative Eyewear, Inc. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2		Certification of Principal Financial Officer of Innovative Eyewear, Inc. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document.
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

 

Signatures

 

Pursuant to the requirements of the Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Innovative Eyewear, Inc.
	(Registrant)
Date: August 12, 2024	By:	/s/ Harrison Gross
		Harrison Gross
		Chief Executive Officer
		(Principal Executive Officer)
Date: August 12, 2024	By:	/s/ Konrad Dabrowski
		Konrad Dabrowski
		Chief Financial Officer
		(Principal Financial Officer and Principal Accounting Officer)

 

 

Exhibit 31.1

 

CERTIFICATIONS

 

I, Harrison Gross, certify that:

 

1.	I have reviewed this Quarterly Report on Form 10-Q of Innovative Eyewear, Inc.;

 

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of a quarterly report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 12, 2024	By:	/s/ Harrison Gross
		Harrison Gross
		Chief Executive Officer
		(Principal Executive Officer)

 

 

Exhibit 31.2

 

CERTIFICATIONS

 

I, Konrad Dabrowski, certify that:

 

1.	I have reviewed this Quarterly Report on Form 10-Q of Innovative Eyewear, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of a quarterly report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 12, 2024	By:	/s/ Konrad Dabrowski
		Konrad Dabrowski
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Innovative Eyewear, Inc. (the “Company”) for the quarterly period ended June 30, 2024, as filed with the Securities and Exchange Commission (the “Report”), I, Harrison Gross, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.

To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the report.

 

Date: August 12, 2024	By:	/s/ Harrison Gross
		Harrison Gross
		Chief Executive Officer
		(Principal Executive Officer)

 

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Innovative Eyewear, Inc. (the “Company”) for the quarterly period ended June 30, 2024, as filed with the Securities and Exchange Commission (the “Report”), I, Konrad Dabrowski, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.

To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the report.

 

Date: August 12, 2024	By:	/s/ Konrad Dabrowski
		Konrad Dabrowski
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

 

v3.24.2.u1

Cover - shares	6 Months Ended
	Jun. 30, 2024	Aug. 08, 2024
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	001-41392
Entity Registrant Name	INNOVATIVE EYEWEAR, INC.
Entity Central Index Key	0001808377
Entity Tax Identification Number	85-0734861
Entity Incorporation, State or Country Code	FL
Entity Address, Address Line One	11900 Biscayne Blvd.
Entity Address, Address Line Two	Suite 630
Entity Address, City or Town	North Miami
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33181
City Area Code	(954)
Local Phone Number	826-0329
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		1,570,569
Common Stock, $0.00001 par value
Title of 12(b) Security	Common Stock, $0.00001 par value
Trading Symbol	LUCY
Security Exchange Name	NASDAQ
Warrants to purchase Common Stock
Title of 12(b) Security	Warrants to purchase Common Stock
Trading Symbol	LUCYW
Security Exchange Name	NASDAQ

v3.24.2.u1

CONDENSED BALANCE SHEETS (Unaudited) - USD ($)		Jun. 30, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	[1]	$ 5,896,889	$ 4,287,447
Accounts receivable, net	[1]	61,613	93,211
Prepaid expenses	[1]	267,410	313,648
Inventory prepayment	[1]	70,779	323,520
Inventory	[1]	930,487	533,239
Due from Tekcapital and Affiliates	[1]		6,256
Other current assets	[1]	59,447	59,447
Total Current Assets	[1]	7,286,625	5,616,768
Non-Current Assets
Patent costs, net	[1]	349,195	286,429
Capitalized software costs	[1]		88,073
Property and equipment, net	[1]	130,645	154,848
Other non-current assets	[1]	92,715	72,644
TOTAL ASSETS	[1]	7,859,180	6,218,762
Current Liabilities
Accounts payable and accrued expenses	[1]	376,544	581,986
Deferred revenue	[1]	42,500	42,500
Due to Tekcapital and Affiliates	[1]	75,591
Total Current Liabilities	[1]	494,635	624,486
Non-Current Liabilities
Deferred revenue	[1]	20,450	35,450
TOTAL LIABILITIES	[1]	515,085	659,936
Commitments and contingencies (see Note 7)	[1]
Stockholders’ Equity
Common stock (par value $0.00001, 50,000,000 shares authorized, and 1,527,034 and 747,416 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively)	[1]	15	7
Additional paid-in capital	[1]	28,233,205	22,528,234
Accumulated deficit	[1]	(20,889,125)	(16,969,415)
TOTAL STOCKHOLDERS’ EQUITY	[1]	7,344,095	5,558,826
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	[1]	$ 7,859,180	$ 6,218,762
[1] Retroactively adjusted the values of Common stock and Additional paid-in capital as well as the number of shares issued and outstanding in order to give effect to the Company’s 1-for-20 reverse stock split. See Note 2 and Note 11.

v3.24.2.u1

CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares		Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Common stock, par value (in Dollars per share)	[1]	$ 0.00001	$ 0.00001
Common stock, shares authorized	[1]	50,000,000	50,000,000
Common stock, shares issued	[1]	1,527,034	747,416
Common stock, shares Outstanding	[1]	1,527,034	747,416
[1] Retroactively adjusted the values of Common stock and Additional paid-in capital as well as the number of shares issued and outstanding in order to give effect to the Company’s 1-for-20 reverse stock split. See Note 2 and Note 11.

v3.24.2.u1

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenues, net		$ 308,682	$ 169,929	$ 692,153	$ 314,850
Less: Cost of Goods Sold		(253,506)	(199,745)	(630,026)	(334,375)
Gross Profit (Deficit)		55,176	(29,816)	62,127	(19,525)
Operating Expenses:
General and administrative		(1,295,299)	(968,354)	(2,404,245)	(1,962,126)
Sales and marketing		(442,433)	(103,643)	(1,103,728)	(362,940)
Research and development		(256,802)	(197,478)	(473,103)	(348,647)
Related party management fee		(35,000)	(35,000)	(70,000)	(70,000)
Total Operating Expenses		(2,029,534)	(1,304,475)	(4,051,076)	(2,743,713)
Other Income		25,959	47,586	69,239	47,662
Interest Expense			(1,097)		(3,036)
Total Other Income (Expense), net		25,959	46,489	69,239	44,626
Net Loss		$ (1,948,399)	$ (1,287,802)	$ (3,919,710)	$ (2,718,612)
Weighted average number of shares outstanding, basic	[1]	1,044,211	503,670	896,685	476,357
Weighted average number of shares outstanding, diluted	[1]	1,044,211	503,670	896,685	476,357
Loss per share, basic	[1]	$ (1.87)	$ (2.56)	$ (4.37)	$ (5.71)
Loss per share, diluted	[1]	$ (1.87)	$ (2.56)	$ (4.37)	$ (5.71)
[1] Retroactively adjusted shares outstanding and per share information to give effect to the Company’s 1-for-20 reverse stock split. See Note 2 and Note 11.

v3.24.2.u1

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)		Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2022		$ 4	$ 14,330,412	$ (10,305,987)	$ 4,024,429
Beginnig balance, shares at Dec. 31, 2022	[1]	434,042
Exercises of warrants by stockholders			1,532,250		1,532,250
Exercises of warrants by stockholders, shares	[1]	22,926
Stock-based compensation			424,431		424,431
Net loss				(1,430,810)	(1,430,810)
Ending balance, value at Mar. 31, 2023		$ 4	16,287,093	(11,736,797)	4,550,300
Ending balance, shares at Mar. 31, 2023	[1]	456,968
Exercises of stock options			17,650		17,650
Exercises of stock options, shares	[1]	11,518
Exercises of warrants by stockholders			1,204,200		1,204,200
Exercises of warrants by stockholders, shares	[1]	18,019
Exercises of warrants related to private placement transaction			391,268		391,268
Exercises of warrants related to private placement transaction, shares	[1]	8,417
Second public offering		$ 3	4,115,685		4,115,688
Second public offering, shares	[1]	252,494
Stock-based compensation			(40,180)		(40,180)
Net loss				(1,287,802)	(1,287,802)
Ending balance, value at Jun. 30, 2023		$ 7	21,975,716	(13,024,599)	8,951,124
Ending balance, shares at Jun. 30, 2023	[1]	747,416
Beginning balance, value at Dec. 31, 2023		$ 7	22,528,234	(16,969,415)	5,558,826	[2]
Beginnig balance, shares at Dec. 31, 2023	[1]	747,416
Issuance of shares to third party service provider			$ 81,900		$ 81,900
Issuance of shares to third party service provider, shares	[1]	15,000
Issuance of shares related to vesting of restricted share units
Issuance of shares related to vesting of restricted share units, shares	[1]	815
Stock-based compensation			$ 232,154		$ 232,154
Net loss				(1,971,311)	(1,971,311)
Ending balance, value at Mar. 31, 2024		$ 7	22,842,288	$ (18,940,726)	3,901,569
Ending balance, shares at Mar. 31, 2024	[1]	763,231
At-the-Market Offerings		$ 3	2,324,576		2,324,579
At-the-Market Offerings, shares	[1]	284,471
First Registered Direct Offering		$ 2	737,298		737,300
First Registered Direct Offering, shares	[1]	210,043
Second Registered Direct Offering		$ 3	2,134,048		2,134,051
Second Registered Direct Offering, shares	[1]	263,159
Issuance of shares to brand ambassador			$ 21,690		$ 21,690
Issuance of shares to brand ambassador, shares	[1]	4,500
Issuance of shares related to vesting of restricted share units
Issuance of shares related to vesting of restricted share units, shares	[1]	1,630
Stock-based compensation			$ 173,305		$ 173,305
Net loss				(1,948,399)	(1,948,399)
Ending balance, value at Jun. 30, 2024		$ 15	$ 28,233,205	$ (20,889,125)	$ 7,344,095	[2]
Ending balance, shares at Jun. 30, 2024	[1]	1,527,034
[1] Retroactively adjusted the values of Common stock and Additional paid-in capital as well as the number of shares issued and outstanding in order to give effect to the Company’s 1-for-20 reverse stock split. See Note 2 and Note 11. [2] Retroactively adjusted the values of Common stock and Additional paid-in capital as well as the number of shares issued and outstanding in order to give effect to the Company’s 1-for-20 reverse stock split. See Note 2 and Note 11.

v3.24.2.u1

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating Activities
Net Loss	$ (3,919,710)	$ (2,718,612)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	59,951	17,816
Amortization	15,297	28,979
Non-cash interest expense		3,036
Stock-based compensation expense	405,459	384,251
Expenses paid by Tekcapital and Affiliates	157,835	151,467
(Recovery of) provision for doubtful accounts	(3,687)	5,814
Write-off of previously-capitalized software costs	88,073
Changes in operating assets and liabilities:
Accounts receivable	50,285	(26,211)
Accounts payable and accrued expenses	(205,442)	(129,714)
Prepaid expenses	96,160	(60,603)
Inventory	(144,507)	(734,042)
Other assets		(10,000)
Contract assets and liabilities	3,597	1,560
Net cash flows from operating activities	(3,396,689)	(3,086,259)
Investing Activities
Loan made to Tekcapital Europe, Ltd.	(767,940)
Repayment of amounts loaned to Tekcapital Europe, Ltd.	767,940
Purchases of debt securities (U.S. Treasury bills)		(1,949,204)
Patent costs	(78,063)	(131,622)
Purchases of property and equipment	(35,748)	(34,435)
Net cash flows from investing activities	(113,811)	(2,115,261)
Financing Activities
Proceeds from second public offering		4,115,688
Proceeds from at-the-market offerings	2,324,579
Proceeds from first registered direct offering	737,300
Proceeds from second registered direct offering	2,134,051
Proceeds from exercises of warrants		3,127,718
Proceeds from exercise of stock options		17,650
Repayment of related party convertible debt		(109,499)
Repayment of amounts due to Tekcapital and Affiliates	(75,988)	(184,701)
Net cash flows from financing activities	5,119,942	6,966,856
Net Change In Cash	1,609,442	1,765,336
Cash at Beginning of Period	4,287,447	3,591,109
Cash at End of Period	5,896,889	5,356,445
Significant Non-Cash Transactions
Expenses paid for by Tekcapital and Affiliates, reported as increase in Due to/from Tekcapital and Affiliates and related party convertible debt	157,835	151,467
Issuance of shares for prepayment to third party service provider	81,900
Issuance of shares for prepayment to brand ambassador	$ 21,690

v3.24.2.u1

GENERAL INFORMATION	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GENERAL INFORMATION	NOTE 1 – GENERAL INFORMATION   Innovative Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd., a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively, together with Lucyd Ltd., “Tekcapital and Affiliates”), which owned approximately 19% of our issued and outstanding shares of common stock and was our largest shareholder as of June 30, 2024. Innovative Eyewear has licensed the exclusive rights to the Lucyd® brand from Lucyd Ltd., which includes the exclusive use of all of Lucyd’s intellectual property, including our main product, Lucyd Lyte® glasses.

v3.24.2.u1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   Basis of Presentation The accompanying condensed balance sheet as of December 31, 2023 (which has been derived from audited financial statements) and the unaudited interim condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.   In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the periods presented have been included. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for future periods or the full year.   Certain prior period amounts have been reclassified to conform to current period presentation; approximately $22,000 of capitalized costs related to the Company’s website previously reported within Capitalized software costs are now reported within Property and equipment, net.   Change in Capital Structure As described more fully in Note 11, effective July 18, 2024, the Company effected a 1-for-20 reverse stock split for all of its issued and outstanding common stock. All share and per share amounts presented in these financial statements and accompanying notes, including but not limited to shares issued and outstanding, dollar amounts of common stock and additional paid-in capital, earnings/(loss) per share, and warrants and options, have been retroactively adjusted for all periods presented in order to reflect this change in capital structure. There were no changes to the total number of authorized common shares or par value per common share as a result of this change.   Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant uncertainties associated with the current geopolitical and economic environment.   Cash Equivalents All highly liquid investments with original maturities of three months or less, including money market funds, certificates of deposit, and U.S. Treasury bills purchased three months or less from maturity, are considered cash equivalents.   Receivables and Credit Policy Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. For direct-to-consumer sales, payment is required before product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net 30” payment terms on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on “net 30” payment terms, the customer is provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for much we will bill the customer via credit card.   Accounts receivable are reported net of an allowance for doubtful accounts. The allowance for doubtful accounts is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management’s assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Receivable balances are written-off against the allowance when such balances are deemed to be uncollectible.   A roll forward of the allowance for doubtful accounts for the six months ended June 30, 2024 and 2023 is as follows:   Schedule of allowance for doubtful accounts                     2024     2023   Balance at January 1   $ 25,772     $ 92,646   Bad debt expense (recovery)     (3,687 )     5,814   Write-offs     -       (142 ) Other     217       -   Balance at June 30   $ 22,302     $ 98,318     Inventory The Company’s inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product.   Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. Such provisions were $0 and $31,637 as of June 30, 2024 and December 31, 2023, respectively.   As of June 30, 2024 and December 31, 2023, the Company recorded an inventory prepayment in the amount of $70,779 and $323,520, respectively, related to down payments for eyewear purchased from the manufacturer, prior to shipment of the product that occurred after the respective balance sheet dates.   Intangible Assets Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents. The Company reviews its intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.   Capitalized Software The Company has incurred software development costs related to development of the Vyrb application, and had previously capitalized approximately $88,000 of these costs related to coding, development, and testing subsequent to establishing technical feasibility of the app, as it was the Company’s intention to market and sell this software externally.   Although we launched Vyrb as an open beta version in 2021, and continued to add new features to the app throughout 2022 and 2023, we had not officially launched the Vyrb app. During 2024, management decided to shift our primary software development focus to the Lucyd app, which was launched in April 2023 as a free application that enables the user to converse with the extremely popular ChatGPT AI language model on our glasses. Certain elements and features developed for the Vyrb app may potentially be incorporated into future releases of the Lucyd app.   Based on this decision, during the three and six months ended June 30, 2024, we expensed the previously-capitalized Vyrb software development costs totalling approximately $88,000 to research and development expense.   Property and Equipment Property and equipment assets are depreciated using the straight-line method over their estimated useful lives or lease terms if shorter. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed as incurred.   Income Taxes The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.   The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.   The Company periodically assesses the realizability of its net deferred tax assets. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.   Stock-Based Compensation The Company recognizes compensation expense for stock-based awards to employees and directors and others based on the grant date fair value of such awards. Forfeitures are accounted for as a reduction of compensation expense in the period when such forfeitures occur.   For stock option awards, the Black-Scholes-Merton option pricing model is used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility.   ● The expected term of the stock options is estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).   ● The share price volatility is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies.   ● The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.   For awards of restricted stock units and shares of common stock, the fair value of the award is based on the quoted market price of our common shares on the NASDAQ stock exchange.   Revenue Recognition Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.com.   To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.   In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received. During the six months ended June 30, 2024 and 2023, we recognized $15,000 of revenue for each period, that was included in the contract liability balances as of January 1, 2024 and 2023, respectively.   All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.   For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. U.S. consumers enjoy free USPS first class postage on orders over $149, with faster delivery options available for extra cost, for sales processed through our website. For Amazon sales, shipping is free for U.S. consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.   For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store, and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.   For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order. If collectibility of substantially all of the contract consideration is probable, revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor, and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to retail store partners and distributors includes volume discounts, due to the nature of large quantity orders. The pricing does not include shipping. Due to the nature of wholesale retail orders, no marketplace fees are applicable, only credit card processing fees.   We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason and receive a full refund for frames (prescription lenses excluded) within the first 7 days for sales made through our website (Lucyd.co), 30 days for sales made through Amazon, and 30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns). As of January 2024, our return policy was updated to prohibit discretionary returns of prescription lenses. Additionally in January 2024, we instituted a standard $15 restocking fee for standard frame returns, which is deducted from applicable refunds to cover shipping and restocking costs.   For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $8,536 and $40,933 as June 30, 2024 and December 31, 2023, respectively.   Amounts billed to a customer for shipping and handling are reported as revenues. Costs incurred for shipping and handling are included in cost of goods sold at the time the related revenue is recognized.

v3.24.2.u1

GOING CONCERN	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 3 – GOING CONCERN   The Company has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditions in the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverse conditions may include recession, downturn, or otherwise, changes in regulations or restrictions in imports, competition, or changes in consumer taste. These adverse conditions could affect the Company’s financial condition and the results of its operations.   The Company meets its day-to-day working capital requirements using monies raised through sales of eyewear and issuances of equity. During the three months ended June 30, 2024, the Company raised approximately $5.2 million of net proceeds through the issuance of equity via a combination of at-the-market offerings and registered direct offerings (see Note 9 for details). The Company has also entered into an agreement with a related party, under which the Company may borrow up to $1.25 million (see Note 6 for details); as of June 30, 2024, the Company has not borrowed any amounts under this agreement. The Company’s forecasts and projections indicate that the Company expects to have sufficient liquidity to fund operations through at least the next 12 months. However, the Company may raise additional funds this year if management believes it would be beneficial.

v3.24.2.u1

INCOME TAX PROVISION	6 Months Ended
	Jun. 30, 2024
Income Tax Disclosure [Abstract]
INCOME TAX PROVISION	NOTE 4 – INCOME TAX PROVISION   At the end of each interim reporting period, the Company estimates its effective tax rate expected to be applied for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods. The Company has not recorded a tax provision for the three and six months ended June 30, 2024 and 2023 as it maintains a full valuation allowance against its net deferred tax assets.

v3.24.2.u1

TANGIBLE AND INTANGIBLE ASSETS	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
TANGIBLE AND INTANGIBLE ASSETS	NOTE 5 – TANGIBLE AND INTANGIBLE ASSETS   Schedule of property, plant and equipment                     June 30,     December 31,   Property & Equipment   2024     2023   Mobile Kiosk Display   $ 160,381     $ 127,333   Computer Equipment     44,901       44,901   Office Equipment     12,991       10,291   Internal-Use Software and Website Costs     53,300       53,300   Property and equipment, gross     271,573       235,825   Less: Accumulated depreciation     (140,928 )     (80,977 ) Property and equipment, net   $ 130,645     $ 154,848     Depreciation expense for the three months ended June 30, 2024 and 2023 was $38,292 and $18,672, respectively.   Depreciation expense for the six months ended June 30, 2024 and 2023 was $59,951 and $28,979, respectively.   Schedule of intangible assets                     June 30,     December 31,   Finite-lived intangible assets   2024     2023   Patent Costs   $ 407,295     $ 329,232   Intangible assets, gross     407,295       329,232   Less: Accumulated amortization     (58,100 )     (42,803 ) Intangible assets, net   $ 349,195     $ 286,429     Amortization expense for the three months ended June 30, 2024 and 2023 was $7,483 and $11,860, respectively.   Amortization expense for the six months ended June 30, 2024 and 2023 was $15,297 and $17,816, respectively.

v3.24.2.u1

RELATED PARTY TRANSACTIONS AND AGREEMENTS	6 Months Ended
	Jun. 30, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS AND AGREEMENTS	NOTE 6 – RELATED PARTY TRANSACTIONS AND AGREEMENTS   Convertible Note and Due to Tekcapital and Affiliates Through December 31, 2023, the Company had the availability of, but not the contractual right to, intercompany financing from Tekcapital and Affiliates in the form of either cash advances or borrowings under a convertible note (as discussed below).   The convertible notes balances were $61,356 at January 1, 2023. In January 2023, the Company borrowed an additional $48,143 under such convertible notes, and subsequently repaid the outstanding balances of the convertible notes in full in February 2023. No further amounts were borrowed under these convertible notes, and the convertible notes matured on December 1, 2023 with no amounts outstanding.   New Lucyd Ltd. Financing Agreement On March 1, 2024, the Company entered into an agreement with Lucyd Ltd. pursuant to which the Company can receive up to $1,250,000 either (a) in services provided by Lucyd Ltd. to the Company or (b) in cash upon request of funds by the Company. Once funds or services are received by the Company, it will issue a convertible note to Lucyd Ltd. that will bear interest at 10% per annum and include the option to convert the note into shares of the Company’s common stock upon certain conversion events. Upon issuance, the convertible note will have a maturity date of September 1, 2025, at which time all outstanding principal and accrued interest, if any, will be payable in full in cash or in the Company’s common stock. The Company will be able to prepay the convertible notes at any time with the written consent of Lucyd Ltd. The Company has not borrowed any amounts under this agreement.   Loan to Tekcapital Europe, Ltd. On January 11, 2024, the Company entered into an intercompany loan agreement (as lender) with Tekcapital Europe, Ltd. (as borrower) and Tekcapital Plc, the parent of Tekcapital Europe, Ltd. Pursuant to this agreement, the Company loaned 600,000 British pounds sterling (equivalent to approximately $768,000) to Tekcapital Europe, Ltd. The loan bore simple interest at a rate of 10% per annum and was required to be repaid on or before April 11, 2024. Tekcapital Plc executed the agreement as guarantor for Tekcapital Europe, Ltd. on the full amount of the loan.   Tekcapital Europe, Ltd. repaid substantially all of the principal balance of the loan in March 2024. As of March 31, 2024, the only amounts remaining outstanding and payable to us under the loan were 7,616 British pounds sterling of principal and 10,717 British pounds sterling of accrued interest (in total, approximately $23,000). These remaining amounts were repaid to us during the three months ended June 30, 2024, and as of June 30, 2024, no amount remains outstanding or payable under this agreement.   Management Service Agreement The Company has entered into a management services agreement with Tekcapital Europe, Ltd., for which the Company is billed at $35,000 quarterly. While the agreement does not stipulate a specific maturity date, it can be terminated with 30 calendar days written notice by any party.   The related party currently provides the following services:     ● Support and advice to the Company in accordance with their area of expertise;     ● Research, technical and legal review, recruitment, software development, marketing, public relations, and advertisement; and     ● Advice, assistance, and consultation services to support the Company or in relation to any other related matter.   During the three months ended June 30, 2024 and 2023, the Company incurred $35,000 in each respective period under the management services agreement. During the six months ended June 30, 2024 and 2023, the Company incurred $70,000 in each respective period under the management services agreement.   Rent of Office Space Under an agreement between the Company and Tekcapital, Tekcapital bills the Company for an allocation of rent paid by Tekcapital on the Company’s behalf. The Company recognized $23,274 and $22,992 of expense related to this month-to-month arrangement for the three months ended June 30, 2024 and 2023, respectively, and recognized $46,505 and $45,760 of expense related to this month-to-month arrangement for the six months ended June 30, 2024 and 2023, respectively.

v3.24.2.u1

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 7 – COMMITMENTS AND CONTINGENCIES   Legal Matters We are not currently the subject of any material pending legal proceedings; however, we may from time to time become a party to various legal proceedings arising in the ordinary course of business.   On January 3, 2024, we settled and resolved certain matters with a third party, including a complaint that had been brought before the International Trade Commission and an investigation instituted by the International Trade Commission in 2023, and entered into a multi-year non-exclusive license agreement with the third party covering multiple smart eyewear patents (as described more fully below).   License Agreements In 2022 and 2023, we entered into various multi-year license agreements which grant us the right to sell certain branded smart eyewear, including the Nautica, Eddie Bauer, and Reebok brands worldwide. These agreements require us to pay royalties based on a percentage of net retail and wholesale sales during the period of the license, and also require guaranteed minimum royalty payments.   The aggregate future minimum payments due under these license agreements are as follows:   Schedule of future minimum payments due           Remainder of 2024     $ -   2025       436,000   2026       834,000   2027       1,290,000   2028       1,543,000   Thereafter (through 2033)       9,907,000   Total     $ 14,010,000     Also, on January 3, 2024, entered into a multi-year non-exclusive license agreement with a third party (IngenioSpec, LLC) for multiple smart eyewear patents. Pursuant to this license agreement, the Company added licenses for 46 new patents to its portfolio of owned and licensed patents and applications. The Company fully prepaid this license for the term of the agreement, and as of June 30, 2024 does not have any obligation for future payments under this agreement.   Leases Our executive offices are located at 11900 Biscayne Blvd., Suite 630 Miami, Florida 33181. Our executive offices are provided to us by a related party (see Note 6). We consider our current office space adequate for our current operations.   Other Commitments See related party management services agreement discussed in Note 6.

v3.24.2.u1

STOCK-BASED COMPENSATION	6 Months Ended
	Jun. 30, 2024
Equity [Abstract]
STOCK-BASED COMPENSATION	NOTE 8 – STOCK-BASED COMPENSATION   Stock Options Summary information regarding the number of options, exercise price, and remaining contractual life as of and during the six months ended June 30, 2024 (as retroactively adjusted for the reverse stock split described in Note 11) is as follows:   Schedule of number of share options and the weighted average exercise price outstanding                             Weighted Average Exercise Price per share ($)     Options (Number)     Weighted Average Remaining Contractual Life (Years)   As at January 1, 2024     41.60       144,726       2.22   Granted     8.40       500           Exercised     -       -           Forfeited / Expired     21.84       (30,750 )         As at June 30, 2024     46.77       114,476       2.14   Exercisable as at June 30, 2024     57.44       83,540       1.46     As of June 30, 2024, the aggregate intrinsic value for all options outstanding as well as all options exercisable was zero 0, and unrecognized stock option expense of approximately $293,000 remains to be recognized over the next 0.71 years.   During the six months ended June 30, 2024, we granted options to purchase an aggregate of 500 shares of common stock at $8.402 per share to an employee, of which 1/5 vested immediately, and 1/5 were to vest on each six-month anniversary of the grant date. The options were to expire on January 11, 2029. However, the employee later separated from the Company, and these options were all forfeited or expired.   Restricted Stock Units During the three and six months ended June 30, 2024, we recognized $5,075 and $10,150 of expense, respectively, related to restricted stock units awarded in 2023; as of June 30, 2024, unrecognized restricted stock unit expense of approximately $8,500 remains to be recognized between July 1, 2024 and November 30, 2024.   Stock Grants On March 28, 2024, we entered into an agreement for a third party to provide us with financial advisory and investment banking services, for a minimum term of six months. As consideration for the services provided to the Company, we issued to the counterparty 15,000 shares of our common stock. The total value of consideration transferred, measured using the fair value of our common stock at the date of issuance, was $81,900. During the three and six months ended June 30, 2024, we recognized $40,950 of expense related to this arrangement, and will recognize the remaining expense of $40,950 during the three months ending September 30, 2024.   On April 1, 2024, we entered into a brand ambassador agreement with an individual for a two-year term. As compensation for the first year of the agreement, we issued the individual 4,500 shares of our common stock. The value of the consideration transferred, measured using the fair value of our common stock at the date of issuance, was $21,690. During the three and six months ended June 30, 2024, we recognized $5,423 of expense related to this arrangement, and will recognize the remaining expense for these shares awarded of $16,267 on a straight-line basis from July 1, 2024 through March 31, 2025.

v3.24.2.u1

STOCKHOLDERS’ EQUITY	6 Months Ended
	Jun. 30, 2024
Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 9 – STOCKHOLDERS’ EQUITY   At-the-Market Offerings On April 15, 2024, the Company entered into an at-the-market offering agreement with H.C. Wainwright & Co., LLC, as sales agent (“HCW”), relating to the sale of common stock.   From April 15, 2024 through April 28, 2024, the Company sold 2,828 shares of common stock and received approximately $13,000 of gross proceeds before deducting sales agent commissions and offering expenses. The net proceeds received by the Company from these transactions amounted to approximately $12,000.   Following the first registered direct offering described below, from May 2, 2024 through May 24, 2024, the Company sold 34,900 shares of common stock and received approximately $536,000 of gross proceeds before deducting sales agent commissions and offering expenses. The net proceeds received by the Company from these transactions amounted to approximately $518,000.   Following the second registered direct offering described below, from June 13, 2024 through June 30, 2024, the Company sold 246,743 shares of common stock and received approximately $1,918,000 of gross proceeds before deducting sales agent commissions and offering expenses, and the net proceeds received by the Company from these transactions amounted to approximately $1,845,000.   The Company also paid $50,000 of legal fees to HCW during the three months ended June 30, 2024; this payment has been reflected in the unaudited condensed financial statements as a reduction to additional paid in capital, as it represents a related cost of the at-the-market equity offering transactions.   First Registered Direct Offering On May 1, 2024, the Company closed on a registered direct offering of 210,043 shares of its common stock and, in a concurrent private placement, warrants to purchase up to 210,043 shares of common stock at an exercise price of $4.88 per share, for a combined purchase price per share and warrant of $4.88. In exchange, the Company received approximately $1.0 million of gross proceeds, before deducting underwriting discounts and offering expenses. In addition, the Company issued to the placement agent warrants to purchase up to 15,754 shares of common stock at an exercise price of $6.10 per share. The net proceeds received by the Company from this transaction amounted to approximately $837,000. We intend to use the net proceeds of this offering primarily for working capital and general corporate purposes.   Approximately $100,000 of the net proceeds received from this registered direct offering were used to pay a former agent for their waiver of a contractual right of first refusal; such payment has been reflected in the unaudited condensed financial statements as a reduction to additional paid in capital, as it represents a related cost of the equity transaction.   Second Registered Direct Offering On May 29, 2024, the Company closed on a registered direct offering of 263,159 shares of its common stock and, in a concurrent private placement, warrants to purchase up to 263,159 shares of common stock at an exercise price of $9.50 per share, for a combined purchase price per share and warrant of $9.50. In exchange, the Company received approximately $2.5 million of gross proceeds, before deducting underwriting discounts and offering expenses. In addition, the Company issued to the placement agent warrants to purchase up to 19,737 shares of common stock at an exercise price of $11.876 per share. The net proceeds received by the Company from this transaction amounted to approximately $2.1 million. We intend to use the net proceeds of this offering primarily for working capital and general corporate purposes.   Other Matters During the three and six months ended June 30, 2024, the Company made a release payment of $325,000 to a shareholder counterparty for the waiver of certain of that counterparty’s pre-existing contractual rights related to the Company’s equity offerings described above. This payment is reflected within General and administrative expenses in the condensed statements of operations.

v3.24.2.u1

EARNINGS PER SHARE	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
EARNINGS PER SHARE	NOTE 10 – EARNINGS PER SHARE   The Company calculates earnings/(loss) per share data by calculating the quotient of earnings/(loss) divided by the weighted average number of common shares outstanding during the respective period.   Due to the net losses for all periods presented in the condensed statements of operations, all shares underlying the common stock options, common stock warrants, and related party convertible debt were excluded from the earnings per share calculation due to their anti-dilutive effect.   The calculation of net earnings/(loss) per share (as retroactively adjusted for the reverse stock split described in Note 11) is as follows:   Schedule of calculation of net earnings per common share - basic and diluted                                     For the three months ended   For the six months ended     June 30, 2024   June 30, 2023   June 30, 2024   June 30, 2023 Basic and diluted:                                 Net loss   $ (1,948,399 )   $ (1,287,802 )   $ (3,919,710 )   $ (2,718,612 ) Weighted-average number of common shares     1,044,211       503,670       896,685       476,357   Basic and diluted net loss per common share   $ (1.87 )   $ (2.56 )   $ (4.37 )   $ (5.71 )

v3.24.2.u1

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 11 – SUBSEQUENT EVENTS   Reverse Stock Split At our annual meeting of shareholders on July 8, 2024, the Company’s shareholders approved an amendment to the Company’s articles of incorporation to effect a reverse stock split of our issued and outstanding common stock at a ratio between 1-for-14 and 1-for-24. Subsequently, the board of directors authorized a reverse stock split in a ratio of 1-for-20 shares, and we filed with the Florida Secretary of State a certificate of amendment to our articles of incorporation.   Effective July 18, 2024, each 20 shares of the Company’s issued and outstanding common stock were combined into one share of common stock, except to the extent that the reverse stock split would have resulted in any of the Company’s stockholders owning a fractional share, in which case such fractional share was rounded up to the next highest whole share. Additionally, pursuant to their terms, the shares of common stock underlying the Company’s outstanding stock options and warrants were similarly adjusted along with corresponding adjustments to their exercise prices.   All share and per share amounts presented in these financial statements and accompanying notes, included but not limited to shares issued and outstanding, earnings/(loss) per share, and warrants and options, as well as the dollar amounts of common stock and additional paid-in capital, have been retroactively adjusted for all periods presented in order to reflect this change in capital structure.   There was no change to the total number of authorized common shares of 50,000,000, and there was no change in the par value per common share of $0.00001.   At-the-Market Offerings On July 11, 2024, the Company further amended its prospectus document, and offered to sell up to $1,446,737 of shares of its common stock from time to time, through HCW acting as agent.   From July 12, 2024 through August 8, 2024, the Company sold 43,535 shares of common stock and received approximately $252,000 of gross proceeds before deducting sales agent commissions and offering expenses. The net proceeds received by the Company from these transactions amounted to approximately $242,000.

v3.24.2.u1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed balance sheet as of December 31, 2023 (which has been derived from audited financial statements) and the unaudited interim condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.   In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the periods presented have been included. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for future periods or the full year.   Certain prior period amounts have been reclassified to conform to current period presentation; approximately $22,000 of capitalized costs related to the Company’s website previously reported within Capitalized software costs are now reported within Property and equipment, net.
Change in Capital Structure	Change in Capital Structure As described more fully in Note 11, effective July 18, 2024, the Company effected a 1-for-20 reverse stock split for all of its issued and outstanding common stock. All share and per share amounts presented in these financial statements and accompanying notes, including but not limited to shares issued and outstanding, dollar amounts of common stock and additional paid-in capital, earnings/(loss) per share, and warrants and options, have been retroactively adjusted for all periods presented in order to reflect this change in capital structure. There were no changes to the total number of authorized common shares or par value per common share as a result of this change.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant uncertainties associated with the current geopolitical and economic environment.
Cash Equivalents	Cash Equivalents All highly liquid investments with original maturities of three months or less, including money market funds, certificates of deposit, and U.S. Treasury bills purchased three months or less from maturity, are considered cash equivalents.
Receivables and Credit Policy	Receivables and Credit Policy Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. For direct-to-consumer sales, payment is required before product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net 30” payment terms on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on “net 30” payment terms, the customer is provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for much we will bill the customer via credit card.   Accounts receivable are reported net of an allowance for doubtful accounts. The allowance for doubtful accounts is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management’s assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Receivable balances are written-off against the allowance when such balances are deemed to be uncollectible.   A roll forward of the allowance for doubtful accounts for the six months ended June 30, 2024 and 2023 is as follows:   Schedule of allowance for doubtful accounts                     2024     2023   Balance at January 1   $ 25,772     $ 92,646   Bad debt expense (recovery)     (3,687 )     5,814   Write-offs     -       (142 ) Other     217       -   Balance at June 30   $ 22,302     $ 98,318
Inventory	Inventory The Company’s inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product.   Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. Such provisions were $0 and $31,637 as of June 30, 2024 and December 31, 2023, respectively.   As of June 30, 2024 and December 31, 2023, the Company recorded an inventory prepayment in the amount of $70,779 and $323,520, respectively, related to down payments for eyewear purchased from the manufacturer, prior to shipment of the product that occurred after the respective balance sheet dates.
Intangible Assets	Intangible Assets Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents. The Company reviews its intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.
Capitalized Software	Capitalized Software The Company has incurred software development costs related to development of the Vyrb application, and had previously capitalized approximately $88,000 of these costs related to coding, development, and testing subsequent to establishing technical feasibility of the app, as it was the Company’s intention to market and sell this software externally.   Although we launched Vyrb as an open beta version in 2021, and continued to add new features to the app throughout 2022 and 2023, we had not officially launched the Vyrb app. During 2024, management decided to shift our primary software development focus to the Lucyd app, which was launched in April 2023 as a free application that enables the user to converse with the extremely popular ChatGPT AI language model on our glasses. Certain elements and features developed for the Vyrb app may potentially be incorporated into future releases of the Lucyd app.   Based on this decision, during the three and six months ended June 30, 2024, we expensed the previously-capitalized Vyrb software development costs totalling approximately $88,000 to research and development expense.
Property and Equipment	Property and Equipment Property and equipment assets are depreciated using the straight-line method over their estimated useful lives or lease terms if shorter. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed as incurred.
Income Taxes	Income Taxes The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.   The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.   The Company periodically assesses the realizability of its net deferred tax assets. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.
Stock-Based Compensation	Stock-Based Compensation The Company recognizes compensation expense for stock-based awards to employees and directors and others based on the grant date fair value of such awards. Forfeitures are accounted for as a reduction of compensation expense in the period when such forfeitures occur.   For stock option awards, the Black-Scholes-Merton option pricing model is used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility.   ● The expected term of the stock options is estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).   ● The share price volatility is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies.   ● The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.   For awards of restricted stock units and shares of common stock, the fair value of the award is based on the quoted market price of our common shares on the NASDAQ stock exchange.
Revenue Recognition	Revenue Recognition Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.com.   To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.   In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received. During the six months ended June 30, 2024 and 2023, we recognized $15,000 of revenue for each period, that was included in the contract liability balances as of January 1, 2024 and 2023, respectively.   All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.   For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. U.S. consumers enjoy free USPS first class postage on orders over $149, with faster delivery options available for extra cost, for sales processed through our website. For Amazon sales, shipping is free for U.S. consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.   For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store, and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.   For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order. If collectibility of substantially all of the contract consideration is probable, revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor, and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to retail store partners and distributors includes volume discounts, due to the nature of large quantity orders. The pricing does not include shipping. Due to the nature of wholesale retail orders, no marketplace fees are applicable, only credit card processing fees.   We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason and receive a full refund for frames (prescription lenses excluded) within the first 7 days for sales made through our website (Lucyd.co), 30 days for sales made through Amazon, and 30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns). As of January 2024, our return policy was updated to prohibit discretionary returns of prescription lenses. Additionally in January 2024, we instituted a standard $15 restocking fee for standard frame returns, which is deducted from applicable refunds to cover shipping and restocking costs.   For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $8,536 and $40,933 as June 30, 2024 and December 31, 2023, respectively.   Amounts billed to a customer for shipping and handling are reported as revenues. Costs incurred for shipping and handling are included in cost of goods sold at the time the related revenue is recognized.

v3.24.2.u1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Schedule of allowance for doubtful accounts	Schedule of allowance for doubtful accounts                     2024     2023   Balance at January 1   $ 25,772     $ 92,646   Bad debt expense (recovery)     (3,687 )     5,814   Write-offs     -       (142 ) Other     217       -   Balance at June 30   $ 22,302     $ 98,318

v3.24.2.u1

TANGIBLE AND INTANGIBLE ASSETS (Tables)	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of property, plant and equipment	Schedule of property, plant and equipment                     June 30,     December 31,   Property & Equipment   2024     2023   Mobile Kiosk Display   $ 160,381     $ 127,333   Computer Equipment     44,901       44,901   Office Equipment     12,991       10,291   Internal-Use Software and Website Costs     53,300       53,300   Property and equipment, gross     271,573       235,825   Less: Accumulated depreciation     (140,928 )     (80,977 ) Property and equipment, net   $ 130,645     $ 154,848
Schedule of intangible assets	Schedule of intangible assets                     June 30,     December 31,   Finite-lived intangible assets   2024     2023   Patent Costs   $ 407,295     $ 329,232   Intangible assets, gross     407,295       329,232   Less: Accumulated amortization     (58,100 )     (42,803 ) Intangible assets, net   $ 349,195     $ 286,429

v3.24.2.u1

COMMITMENTS AND CONTINGENCIES (Tables)	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of future minimum payments due	Schedule of future minimum payments due           Remainder of 2024     $ -   2025       436,000   2026       834,000   2027       1,290,000   2028       1,543,000   Thereafter (through 2033)       9,907,000   Total     $ 14,010,000

v3.24.2.u1

STOCK-BASED COMPENSATION (Tables)	6 Months Ended
	Jun. 30, 2024
Equity [Abstract]
Schedule of number of share options and the weighted average exercise price outstanding	Schedule of number of share options and the weighted average exercise price outstanding                             Weighted Average Exercise Price per share ($)     Options (Number)     Weighted Average Remaining Contractual Life (Years)   As at January 1, 2024     41.60       144,726       2.22   Granted     8.40       500           Exercised     -       -           Forfeited / Expired     21.84       (30,750 )         As at June 30, 2024     46.77       114,476       2.14   Exercisable as at June 30, 2024     57.44       83,540       1.46

v3.24.2.u1

EARNINGS PER SHARE (Tables)	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
Schedule of calculation of net earnings per common share - basic and diluted	Schedule of calculation of net earnings per common share - basic and diluted                                     For the three months ended   For the six months ended     June 30, 2024   June 30, 2023   June 30, 2024   June 30, 2023 Basic and diluted:                                 Net loss   $ (1,948,399 )   $ (1,287,802 )   $ (3,919,710 )   $ (2,718,612 ) Weighted-average number of common shares     1,044,211       503,670       896,685       476,357   Basic and diluted net loss per common share   $ (1.87 )   $ (2.56 )   $ (4.37 )   $ (5.71 )

v3.24.2.u1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Accounting Policies [Abstract]
Balance at begining	$ 25,772	$ 92,646
Bad debt expense (recovery)	(3,687)	5,814
Write-offs		(142)
Other	217
Balance at end	$ 22,302	$ 98,318

v3.24.2.u1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
		Jan. 31, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Provisions for excess, obsolete, or slow-moving inventory					$ 0		$ 31,637
Inventory prepayment	[1]		$ 70,779		70,779		323,520
Research and development expense			256,802	$ 197,478	473,103	$ 348,647
Contract liability balance					15,000	$ 15,000
Restocking fee		$ 15
Allowance for sales returns			8,536		8,536		$ 40,933
Software Development [Member]
Property, Plant and Equipment [Line Items]
Research and development expense			$ 88,000		$ 88,000
[1] Retroactively adjusted the values of Common stock and Additional paid-in capital as well as the number of shares issued and outstanding in order to give effect to the Company’s 1-for-20 reverse stock split. See Note 2 and Note 11.

v3.24.2.u1

INCOME TAX PROVISION (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Income tax positions	$ 0	$ 0	$ 0	$ 0

v3.24.2.u1

TANGIBLE AND INTANGIBLE ASSETS (Details) - USD ($)		Jun. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property and equipment, gross		$ 271,573	$ 235,825
Less: Accumulated depreciation		(140,928)	(80,977)
Property and equipment, net	[1]	130,645	154,848
Mobile Kiosk Display [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross		160,381	127,333
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross		44,901	44,901
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross		12,991	10,291
Internal Use Software And Website Costs [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross		$ 53,300	$ 53,300
[1] Retroactively adjusted the values of Common stock and Additional paid-in capital as well as the number of shares issued and outstanding in order to give effect to the Company’s 1-for-20 reverse stock split. See Note 2 and Note 11.

v3.24.2.u1

TANGIBLE AND INTANGIBLE ASSETS (Details 1) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 407,295	$ 329,232
Less: Accumulated amortization	(58,100)	(42,803)
Intangible assets, net	349,195	286,429
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 407,295	$ 329,232

v3.24.2.u1

TANGIBLE AND INTANGIBLE ASSETS (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Depreciation expense	$ 38,292	$ 18,672	$ 59,951	$ 28,979
Amortization expense	$ 7,483	$ 11,860	$ 15,297	$ 17,816

v3.24.2.u1

RELATED PARTY TRANSACTIONS AND AGREEMENTS (Details Narrative) - USD ($)			1 Months Ended	3 Months Ended		6 Months Ended
	Mar. 02, 2024	Jan. 11, 2024	Jan. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Jan. 02, 2023
Related Party Transaction [Line Items]
Convertible notes balances								$ 61,356
Convertible notes issued			$ 48,143
Management fee				$ 35,000	$ 35,000	$ 70,000	$ 70,000
Tekcapital Europe Ltd [Member]
Related Party Transaction [Line Items]
Interest rate		10.00%
Maturity date		Apr. 11, 2024
Loans payable		$ 768,000		23,000		23,000
Management fee				35,000	35,000	70,000	70,000
Rent expenses				$ 23,274	$ 22,992	$ 46,505	$ 45,760
New Lucyd Ltd. Agreement [Member] | Lucyd Ltd [Member]
Related Party Transaction [Line Items]
Receivables amount	$ 1,250,000
Interest rate	10.00%
Maturity date	Sep. 01, 2025

v3.24.2.u1

COMMITMENTS AND CONTINGENCIES (Details)	Jun. 30, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of 2024
2025	436,000
2026	834,000
2027	1,290,000
2028	1,543,000
Thereafter (through 2033)	9,907,000
Total	$ 14,010,000

v3.24.2.u1

STOCK-BASED COMPENSATION (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Equity [Abstract]
Weighted avaerage exercise price per share, Option Outstanding at beginnig	$ 41.60
Option Outstanding at beginnig	144,726
Weighted avaerage remaining contractual life (Years)	2 years 1 month 20 days	2 years 2 months 19 days
Weighted avaerage exercise price per share, Option Granted	$ 8.40
Option Granted	500
Weighted avaerage exercise price per share, Option Exercised
Option Exercised
Weighted avaerage exercise price per share, Option Forfeited / Expired	$ 21.84
Option Forfeited / Expired	(30,750)
Weighted avaerage exercise price per share, Option Outstanding at ending	$ 46.77	$ 41.60
Option Outstanding at ending	114,476	144,726
Weighted avaerage exercise price per share, Option Exercisable	$ 57.44
Option Exercisable	83,540
Weighted avaerage remaining contractual life (Years), Option Exercisable	1 year 5 months 15 days

v3.24.2.u1

STOCK-BASED COMPENSATION (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended	6 Months Ended
	Apr. 02, 2024	Mar. 28, 2024	Jun. 30, 2024	Jun. 30, 2024	Sep. 30, 2024
Options outstanding intrinsic value			$ 0	$ 0
Options exercisable intrinsic value			0	0
Unrecognized stock compensation expense			293,000	$ 293,000
Unrecognized stock compensation expense, term				8 months 15 days
Restricted stock units expense			5,075	$ 10,150
Unrecognized restricted stock unit expense			8,500	8,500	$ 40,950
Number of total value		$ 81,900
Stock grants expenses			40,950	40,950
Brand Ambassador Agreement [Member]
Number of total value	$ 21,690
Stock grants expenses			$ 5,423	$ 16,267
Employee [Member]
Number of options purchased				500
Exercise price				$ 8.402
Counterparty [Member]
Number of stock issued		15,000
Individual Counterparty [Member] | Brand Ambassador Agreement [Member]
Number of stock issued	4,500

v3.24.2.u1

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)			1 Months Ended				3 Months Ended	6 Months Ended
	May 01, 2024	Apr. 28, 2024	Aug. 08, 2024	Jun. 30, 2024	May 29, 2024	May 24, 2024	Jun. 30, 2024	Jun. 30, 2024
Subsidiary, Sale of Stock [Line Items]
Number of stock sold, shares		2,828	43,535
Received on gross proceeds		$ 13,000	$ 252,000
Proceeds received on transaction		$ 12,000	$ 242,000
Release payment							$ 325,000	$ 325,000
H C W [Member]
Subsidiary, Sale of Stock [Line Items]
Legal fees							$ 50,000
First Registered Direct Offering [Member] | Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price	$ 4.88
Second Registered Direct Offering [Member] | Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price					$ 9.50
First Registered Direct Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Number of stock sold, shares						34,900
Received on gross proceeds						$ 536,000
Proceeds received on transaction						$ 518,000
Number of shares offering	210,043
Number of warrants purchased	210,043
First Registered Direct Offering [Member] | Placement Agent [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds received on transaction	$ 837,000
Number of warrants purchased	15,754
Exercise price	$ 6.10
First Registered Direct Offering [Member] | Former Agent [Member]
Subsidiary, Sale of Stock [Line Items]
Reduction to additional paid in capital	$ 100,000
First Registered Direct Offering [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price	$ 4.88
Second Registered Direct Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Number of stock sold, shares				246,743
Received on gross proceeds				$ 1,918,000
Proceeds received on transaction				$ 1,845,000
Number of shares offering					263,159
Number of warrants purchased					263,159
Second Registered Direct Offering [Member] | Placement Agent [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds received on transaction					$ 2,100,000
Number of warrants purchased					19,737
Exercise price					$ 11.876
Second Registered Direct Offering [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price					$ 9.50

v3.24.2.u1

EARNINGS PER SHARE (Details) - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Earnings Per Share [Abstract]
Net loss		$ (1,948,399)	$ (1,287,802)	$ (3,919,710)	$ (2,718,612)
Weighted-average number of common shares, basic	[1]	1,044,211	503,670	896,685	476,357
Weighted-average number of common shares, diluted	[1]	1,044,211	503,670	896,685	476,357
Basic net loss per common share	[1]	$ (1.87)	$ (2.56)	$ (4.37)	$ (5.71)
Diluted net loss per common share	[1]	$ (1.87)	$ (2.56)	$ (4.37)	$ (5.71)
[1] Retroactively adjusted shares outstanding and per share information to give effect to the Company’s 1-for-20 reverse stock split. See Note 2 and Note 11.

v3.24.2.u1

SUBSEQUENT EVENTS (Details Narrative) - USD ($)				1 Months Ended
	Jul. 11, 2024	Jul. 08, 2024	Apr. 28, 2024	Aug. 08, 2024	Jun. 30, 2024	[1]	Dec. 31, 2023	[1]
Common stock, shares authorized		50,000,000			50,000,000		50,000,000
Common stock, par value		$ 0.00001			$ 0.00001		$ 0.00001
Proceeds received on transaction			$ 12,000	$ 242,000
Number of stock sold, shares			2,828	43,535
Received on gross proceeds			$ 13,000	$ 252,000
Shareholders [Member]
Reverse stock split		Company’s shareholders approved an amendment to the Company’s articles of incorporation to effect a reverse stock split of our issued and outstanding common stock at a ratio between 1-for-14 and 1-for-24
Director [Member]
Reverse stock split		1-for-20
H C W [Member]
Proceeds received on transaction	$ 1,446,737
[1] Retroactively adjusted the values of Common stock and Additional paid-in capital as well as the number of shares issued and outstanding in order to give effect to the Company’s 1-for-20 reverse stock split. See Note 2 and Note 11.

---